ACE - Audit Report / Information 2020

Jinan Acetate Chemical Co., Ltd. and Subsidiaries

Consolidated Financial Statements for the Years Ended December 31, 2020 and 2019 and Independent Auditors’ Report

INDEPENDENT AUDITORS’ REPORT

The Board of Directors and Shareholders Jinan Acetate Chemical Co., Ltd.

Opinion

We have audited the accompanying consolidated financial statements of Jinan Acetate Chemical Co., Ltd. (the “Company”) and its subsidiaries (collectively referred to as the “Group”), which comprise the consolidated balance sheets as of December 31, 2020 and 2019, and the consolidated statements of comprehensive income, changes in equity and cash flows for the years then ended, and the notes to the consolidated financial statements, including a summary of significant accounting policies (collectively referred to as the “consolidated financial statements”).

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as of December 31, 2020 and 2019, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and International Financial Reporting Standards (IFRS), International Accounting Standards (IAS), IFRIC Interpretations (IFRIC), and SIC Interpretations (SIC) endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and auditing standards generally accepted in the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with The Norm of Professional Ethics for Certified Public Accountant of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements for the year ended December 31, 2020. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Key audit matters of the Group’s consolidated financial statements for the year ended December 31, 2020 are stated as follows:

Occurrence of Operating Revenue Recognize in Substantial Growth of Customers Sales

At the year ended December 31, 2020, the Group’s revenue increased compare to the year ended December 31, 2019. In 2020, among part of the Group’s customers have substantial growth in operating revenue than previous year. We, therefore, consider the recognition of operating revenue growth with customers sales, which have substantial growth in operating revenue than previous year as a key audit matter. Please refer to Notes 4 and 22 to the consolidated financial statements for the relevant accounting policy.

The key audit procedures performed in respect of the above area included the following:

We obtained on understanding of the Group’s policies procedures and internal controls for revenue recognition and tested the effectiveness and efficiency of operations of the key controls over the occurrence of revenue recognize.
We analyzed the sales customers, which mentioned above, with the reason for the change in operating revenue.
We selected the sample transactions of the sales customers, which mentioned above, in the sales records for substantive tests and confirmed them with the supporting shipping documents, and verified the collection after the reporting period.
We inspected any major sales return and discount within the sales customer after the reporting period.

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and the IFRS, IAS, IFRIC, and SIC endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including members of the audit committee are responsible for overseeing the Group’s financial reporting process.

Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the auditing standards generally accepted in the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with the auditing standards generally accepted in the Republic of China, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Group to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient and appropriate audit evidence regarding the financial information of entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision, and performance of the group audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements for the year ended December 31, 2020 and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audit resulting in this independent auditors’ report are Tung-Feng Lee and Yao-Ling Huang.

Deloitte & Touche Taipei, Taiwan Republic of China

March 5, 2021

Notice to Readers

The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such consolidated financial statements are those generally applied in the Republic of China.

For the convenience of readers, the independent auditors’ report and the accompanying consolidated financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chinese-language independent auditors’ report and consolidated financial statements shall prevail.

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS DECEMBER 31, 2020 AND 2019

(In Thousands of New Taiwan Dollars)

ASSETS CURRENT ASSETS Cash and cash equivalents (Notes 4 and 6) Financial assets at amortized cost - current (Notes 4, 9 and 29) Notes and accounts receivable, net (Notes 4, 10 and 22) Accounts receivable from related parties (Notes 4, 10, 22 and 28) Other receivables (Note 4) Current tax assets (Notes 4 and 24) Inventories, net (Notes 4 and 11) Prepayments (Notes 16 and 28) Other current assets (Notes 4, 28 and 29) Total current assets NON-CURRENT ASSETS Financial assets at fair value through other comprehensive income - non-current (Notes 4 and 8) Property, plant and equipment (Notes 4, 13 and 29) Right-of-use assets (Notes 4, 14 and 29) Investment properties, net (Notes 4, 15 and 29) Deferred tax assets (Notes 4 and 24) Other non-current assets (Note 4 and 16) Total non-current assets TOTAL LIABILITIES AND EQUITY CURRENT LIABILITIES Short-term borrowings (Note 17) Financial liabilities at fair value through profit or loss - current (Notes 4, 7 and 18) Contract liabilities - current (Note 22) Notes and accounts payable, net (Note 28) Other payables (Notes 19 and 28) Current portion of bonds payable (Notes 4 and 18) Other current liabilities Total current liabilities NON-CURRENT LIABILITIES Financial liabilities at fair value through profit or loss - non-current (Notes 4, 7 and 18) Bonds payable (Notes 4 and 18) Deferred tax liabilities (Notes 4 and 24) Total non-current liabilities Total liabilities EQUITY ATTRIBUTABLE TO OWNERS OF THE COMPANY (Notes 4 and 21) Share capital Ordinary Shares Capital surplus Retained earnings Legal reserve Special reserve Unappropriated earnings Total retained earnings Other equity Exchange differences on translating the financial statements of foreign operations Unrealized valuation loss on financial assets at fair value through other comprehensive income Revaluation surplus Total other equity Treasury shares Total equity attributable to owners of the Company NON-CONTROLLING INTERESTS Total equity TOTAL		2020 Amount % $ 831,330 27 4,865 - 586,078 19 75,387 3 35,585 1 3,628 - 219,979 7 63,982 2 92,318 3 1,913,152 62 25,829 1 898,321 29 53,811 2 101,897 3 34,080 1 81,977 2 1,195,915 38 $ 3,109,067 100 $ 56,960 2 21,798 1 47,573 1 157,488 5 156,896 5 473,921 15 1,657 - 916,293 29 61,140 2 513,646 17 9,577 - 584,363 19 1,500,656 48 510,767 17 433,575 14 133,588 4 78,601 3 509,525 16 721,714 23 (110,395) (4) (15,619) - 65,146 2 (60,868) (2) (115,905) (4) 1,489,283 48 119,128 4 1,608,411 52 $ 3,109,067 100		2019
				Amount % $ 589,261 23 98,106 4 350,644 14 87,249 3 26,128 1 14,028 - 242,969 9 54,319 2 67,065 3 1,529,769 59 31,716 1 826,705 32 55,248 2 100,220 4 21,533 1 21,083 1 1,056,505 41 $ 2,586,274 100 $ 299,800 11 46,300 2 16,450 1 222,386 9 157,288 6 456,564 18 5,382 - 1,204,170 47 - - - - 9,420 - 9,420 - 1,213,590 47 510,767 20 433,575 17 100,620 4 21,406 1 332,779 13 454,805 18 (130,806) (5) (10,597) - 65,146 2 (76,257) (3) (63,586) (3) 1,259,304 49 113,380 4 1,372,684 53 $ 2,586,274 100

The accompanying notes are an integral part of the consolidated financial statements.

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

OPERATING REVENUE (Notes 4, 22 and 28) OPERATING COSTS (Notes 11, 23 and 28) GROSS PROFIT OPERATING EXPENSES (Notes 23 and 28) Selling and marketing expenses General and administrative expenses Research and development expenses Total operating expenses PROFIT FROM OPERATIONS NON-OPERATING INCOME AND EXPENSES (Note 23) Other income Other gains and losses Finance costs Interest income Net gain on fair value changes of financial liabilities at fair value through profit or loss (Note 18) Total non-operating income and expenses PROFIT BEFORE INCOME TAX INCOME TAX EXPENSE (Notes 4 and 24) NET PROFIT FOR THE YEAR		2020 Amount % $ 2,353,380 100 (1,564,853) (67) 788,527 33 (126,578) (5) (65,306) (3) (97,428) (4) (289,312) (12) 499,215 21 49,077 2 (27,010) (1) (25,860) (1) 1,778 - 55,650 2 53,635 2 552,850 23 (43,269) (2) 509,581 21		2019
				Amount % $ 2,174,990 100 (1,501,761) (69) 673,229 31 (116,685) (5) (68,725) (3) (96,675) (5) (282,085) (13) 391,144 18 26,859 1 (19,228) (1) (23,347) (1) 2,833 - 100 - (12,783) (1) 378,361 17 (47,104) (2) 331,257 15 (Continued)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

OTHER COMPREHENSIVE INCOME (LOSS) (Note 4) Items that will not be reclassified subsequently to profit or loss Unrealized loss on investments in equity instruments at fair value through other comprehensive income Exchange differences arising on translation to the presentation currency Total other comprehensive income (loss) TOTAL COMPREHENSIVE INCOME FOR THE YEAR NET PROFIT ATTRIBUTABLE TO: Owners of the Company Non-controlling interests TOTAL COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO: Owners of the Company Non-controlling interests EARNINGS PER SHARE (NT$, Note 25) Basic Diluted		2020 Amount % $ (6,278) - 22,392 1 16,114 1 $ 525,695 22 $ 504,558 22 5,023 - $ 509,581 22 $ 519,947 22 5,748 - $ 525,695 22 $ 10.07 $ 9.87		2019
				Amount % $ (13,246) (1) (51,226) (2) (64,472) (3) $ 266,785 12 $ 329,677 15 1,580 - $ 331,257 15 $ 272,482 12 (5,697) - $ 266,785 12 $ 6.52 $ 6.40

		$		$
		$		$
		$		$
		$		$
		$		$

The accompanying notes are an integral part of the consolidated financial statements.

(Concluded)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars)

		Equity Attributable to Owners of the Company	Equity Attributable to Owners of the Company	Equity Attributable to Owners of the Company	Equity Attributable to Owners of the Company
Share Capital Shares (In Thousands) Amount 46,480 $ 464,800 - - - - - - - - - - - - - - 4,597 45,967 - - - - 51,077 510,767 - - - - - - - - - - - - - - - - 51,077 $ 510,767	Capital Surplus $ 479,542 - - - - - - - (45,967) - - 433,575 - - - - - - - - $ 433,575	Retained Earnings	Total $ 308,996 - - (183,868) (183,868) 329,677 - 329,677 - - - 454,805 - - (237,649) (237,649) 504,558 - 504,558 - $ 721,714	Other Equity		Total $ (19,062) - - - - - (57,195) (57,195) - - - (76,257) - - - - - 15,389 15,389 - $ (60,868 )	Treasury Shares $ (52,124) - - - - - - - - (11,462) - (63,586) - - - - - - - (52,319) $ (115,905 )
				Exchange Differences on Translating the Financial Statements of Unrealized Valuation Gain (Loss) on Financial Assets at Fair Value Through Other Foreign Comprehensive Operations Income $ (84,208) $ - - - - - - - - - - - (46,598) (10,597) (46,598) (10,597) - - - - - - (130,806) (10,597) - - - - - - - - - - 20,411 (5,022) 20,411 (5,022) - - $ (110,395 ) $ (15,619 )	Gains on Property Revaluation $ 65,146 - - - - - - - - - - 65,146 - - - - - - - - $ 65,146
Shares (In Thousands) 46,480 - - - - - - - 4,597 - - 51,077 - - - - - - - - 51,077		Unappropriated Legal Reserve Special Reserve Earnings $ 78,110 $ 2,344 $ 228,542 22,510 - (22,510 ) - 19,062 (19,062 ) - - (183,868) 22,510 19,062 (225,440) - - 329,677 - - - - - 329,677 - - - - - - - - - 100,620 21,406 332,779 32,968 - (32,968 ) - 57,195 (57,195 ) - - (237,649) 32,968 57,195 (327,812) - - 504,558 - - - - - 504,558 - - - $ 133,588 $ 78,601 $ 509,525

The accompanying notes are an integral part of the consolidated financial statements.

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars)

CASH FLOWS FROM OPERATING ACTIVITIES Income before income tax Adjustments for: Depreciation expenses Net gain on fair value changes of financial liabilities at fair value through profit or loss Finance costs Interest income Loss on disposal of property, plant and equipment Write-downs of inventories Changes in operating assets and liabilities Notes receivable Accounts receivable Accounts receivable from related parties Other receivables Inventories Prepayments Other current assets Contract liabilities Notes and accounts payable Other payables Other current liabilities Cash generated from operations Interest paid Income taxes paid Net cash generated from operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of financial assets at fair value through other comprehensive income Purchase of financial assets at amortized cost Proceeds from disposal of financial assets at amortized cost Payments for property, plant and equipment Proceeds from disposal of property, plant and equipment Decrease in refundable deposits Decrease in other non-current assets Increase in prepayments for equipment Interest received Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from (repayments of) short-term borrowings Proceeds from issuance of convertible bonds	2020 $ 552,850 105,376 (55,650) 25,860 (1,778) 22 267 (137,307) (98,127) 11,862 (8,822) 22,723 (9,663) (25,253) 31,123 (64,898) (392) (2,682) 345,511 (3,993) (46,796) 294,722 - (3,798) 98,680 (141,008) 2 - 1,368 (80,162) 1,143 (123,775) (236,400) 601,416	2019 $ 378,361 98,227 (100) 23,347 (2,833) 34 657 (15,768) (71,963) (38,099) (8,741) 77,069 28,999 56,525 9,254 (22,813) (91) 1,331 513,396 (6,625) (41,048) 465,723 (47,308) (98,106) 633 (84,453) 14 15 12,260 (20,442) 1,957 (235,430) 191,654 - (Continued)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars)

Proceeds from (refund of) guarantee deposits received Dividends paid to owners of the Company Payments for buy-back of ordinary shares Increase in non-controlling interests Net cash generated from financing activities EFFECTS OF EXCHANGE RATE CHANGES ON THE BALANCE OF CASH HELD IN FOREIGN CURRENCIES NET INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR	2020 $ (1,042) (237,649) (52,319) - 74,006 (2,884) 242,069 589,261 $ 831,330	2019 $ 1,318 (183,868) (11,462) 9,782 7,424 (17,534) 220,183 369,078 $ 589,261

The accompanying notes are an integral part of the consolidated financial statements.

(Concluded)

10 -

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

1. GENERAL INFORMATION

Jinan Acetate Chemical Co., Ltd. (the “Company”) was incorporated in Cayman Islands on September 25, 2014. The Company was established mainly for organizational restructuring. In accordance with the equity exchange agreement, the Company has become the holding company of the consolidated entities after the organizational restructuring have been completed on September 25, 2014.

The Company’s shares have been listed on the Taiwan Stock Exchange (TSE) since November 9, 2015.

The Company’s functional currency is Renminbi. However, due to the listing in the TSE, the consolidated financial statements are presented in New Taiwan dollars for greater comparability and consistency of financial reporting.

2. APPROVAL OF FINANCIAL STATEMENTS

The consolidated financial statements were approved by the Company’s board of directors on March 5, 2021.

3. APPLICATION OF NEW, AMENDED AND REVISED STANDARDS AND INTERPRETATIONS

a. Initial application of the amendments to the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards (IFRS), International Accounting Standards (IAS), IFRS Interpretations (IFRIC), and SIC Interpretations (SIC) (collectively, the “IFRSs”) endorsed and issued into effect by the Financial Supervisory Commission (FSC)

Except for the following, the initial application of the amendments to the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the IFRSs endorsed and issued into effect by the FSC did not have any material impact on the Group’s accounting policies.

b. The IFRSs endorsed by the Financial Supervisory Commission (FSC) for application starting from 2021

New IFRSs Amendments to IFRS 4 “Extension of the Temporary Exemption from Applying IFRS 9” Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 “Interest Rate Benchmark Reform - Phase 2” Amendment to IFRS 16 “Covid-19 - Related Rent Concessions”	Effective Date Announced by International Accounting Standards Board (IASB)
	Effective immediately upon promulgation by the IASB January 1, 2021 June 1, 2020

As of the date the consolidated financial statements were authorized for issue, the Group is continuously assessing the possible impact that the application of other standards and interpretations will have on the Group’s financial position and financial performance and will disclose the relevant impact when the assessment is completed.

11 -
c. New IFRSs in issue but not yet endorsed and issued into effect by the FSC

Effective Date New IFRSs Announced by IASB (Note 1) “Annual Improvements to IFRS Standards 2018-2020” January 1, 2022 (Note 2) Amendments to IFRS 3 “Reference to the Conceptual Framework” January 1, 2022 (Note 3) Amendments to IAS 10 and IAS 28 “Sale or Contribution of Assets To be determined by IASB between an Investor and its Associate or Joint Venture” IFRS 17 “Insurance Contracts” January 1, 2023 Amendments to IFRS 17 January 1, 2023 Amendments to IAS 1 “Classification of Liabilities as Current or January 1, 2023 Non-current” Amendments to IAS 1 “Disclosure of Accounting Policies” January 1, 2023 (Note 6) Amendments to IAS 8 “Definition of Accounting Estimates” January 1, 2023 (Note 7) Amendments to IAS 16 “Property, Plant and Equipment - Proceeds January 1, 2022 (Note 4) before Intended Use” Amendments to IAS 37 “Onerous Contracts - Cost of Fulfilling a January 1, 2022 (Note 5) Contract”

Note 1: Unless stated otherwise, the above New IFRSs are effective for annual reporting periods beginning on or after their respective effective dates.
Note 2: The amendments to IFRS 9 will be applied prospectively to modifications and exchanges of financial liabilities that occur on or after the annual reporting periods beginning on or after January 1, 2022. The amendments to IAS 41 “Agriculture” will be applied prospectively to the fair value measurements on or after the annual reporting periods beginning on or after January 1, 2022. The amendments to IFRS 1 “First-time Adoptions of IFRSs” will be applied retrospectively for annual reporting periods beginning on or after January 1, 2022.
Note 3: The amendments are applicable to business combinations for which the acquisition date is on or after the beginning of the annual reporting period beginning on or after January 1, 2022.
Note 4: The amendments are applicable to property, plant and equipment that are brought to the location and condition necessary for them to be capable of operating in the manner intended by management on or after January 1, 2021.
Note 5: The amendments are applicable to contracts for which the entity has not yet fulfilled all its obligations on January 1, 2022.
Note 6: The amendments will be applied prospectively for annual reporting periods beginning on or after January 1, 2023.
Note 7: The amendments are applicable to changes in accounting estimates and changes in accounting policies that occur on or after the beginning of the annual reporting period beginning on or after January 1, 2023.

12 -

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a. Statement of compliance

The consolidated financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and IFRSs endorsed and issued into effect by the FSC.

b. Basis of preparation

The consolidated financial statements have been prepared on the historical cost basis except for the financial instruments and investment properties which are measured at fair value.

The fair value measurements, which are grouped into Levels 1 to 3 based on the degree to which the fair value measurement inputs are observable and based on the significance of the inputs to the fair value measurement in its entirety, are described as follows:

1) Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities;
2) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and
3) Level 3 inputs are unobservable inputs for the asset or liability.
c. Classification of current and non-current assets and liabilities

Current assets include:

1) Assets held primarily for the purpose of trading;
2) Assets expected to be realized within 12 months after the reporting period; and
3) Cash and cash equivalents unless the asset is restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period.

Current liabilities include:

1) Liabilities held primarily for the purpose of trading;
2) Liabilities due to be settled within 12 months after the reporting period; and
3) Liabilities for which the Group does not have an unconditional right to defer settlement for at least 12 months after the reporting period.

Assets and liabilities that are not classified as current are classified as non-current.

d. Basis of consolidation

The consolidated financial statements incorporate the financial statements of the Company and the entities controlled by the Company (i.e. its subsidiaries).

Income and expenses of subsidiaries acquired or disposed of during the period are included in the consolidated statement of profit or loss and other comprehensive income from the effective dates of acquisitions up to the effective dates of disposals, as appropriate.

13 -

When necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by the Company.

All intra-group transactions, balances, income and expenses are eliminated in full upon consolidation. Total comprehensive income of subsidiaries is attributed to the owners of the Company and to the non-controlling interests even if this results in the non-controlling interests having a deficit balance.

Changes in the Group’s ownership interests in subsidiaries that do not result in the Group losing control over the subsidiaries are accounted for as equity transactions. The carrying amounts of the interests of the Group and the non-controlling interests are adjusted to reflect the changes in their relative interests in the subsidiaries. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recognized directly in equity and attributed to the owners of the Company.

See Note 12, Tables 6 and 7 for the detailed information of subsidiaries (including percentages of ownership and main businesses).

e. Foreign currencies

In preparing the financial statements of each individual group entity, transactions in currencies other than the entity’s functional currency (i.e., foreign currencies) are recognized at the rates of exchange prevailing at the dates of the transactions.

At the end of each reporting period, monetary items denominated in foreign currencies are retranslated at the rates prevailing at that date. Exchange differences on monetary items arising from settlement or translation are recognized in profit or loss in the period in which they arise.

Non-monetary items measured at fair value that are denominated in foreign currencies are retranslated at the rates prevailing at the date when the fair value was determined. Exchange differences arising from the retranslation of non-monetary items are included in profit or loss for the period except for exchange differences arising from the retranslation of non-monetary items in respect of which gains and losses are recognized directly in other comprehensive income, in which cases, the exchange differences are also recognized directly in other comprehensive income.

Non-monetary items that are measured at historical cost in a foreign currency are not retranslated.

For the purpose of presenting consolidated financial statements, the functional currencies of the Company and the other entities in the Group (including subsidiaries and branches in other countries that use currency which are different from the currency of the Company) are translated into the presentation currency - the New Taiwan dollar as follows: Assets and liabilities are translated at the exchange rates prevailing at the end of the reporting period; and income and expense items are translated at the average exchange rates for the period. The resulting currency translation differences are recognized in other comprehensive income (attributed to the owners of the Company and non-controlling interests as appropriate).

f. Inventories

Inventories consist of raw materials, supplies, finished goods and work in progress and are stated at the lower of cost or net realizable value. Inventory write-downs are made by item, except where it may be appropriate to group similar or related items. The net realizable value is the estimated selling price of inventories less all estimated costs of completion and costs necessary to make the sale. Inventories are recorded at the weighted-average cost on the balance sheet date.

14 -

g. Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost less accumulated depreciation and accumulated impairment loss.

Property, plant and equipment in the course of construction are measured at cost less any recognized impairment loss. Cost includes professional fees and borrowing costs eligible for capitalization. Such assets are depreciated and classified to the appropriate categories of property, plant and equipment when completed and ready for their intended use.

The depreciation of property, plant and equipment is recognized using the straight-line method. Each significant part is depreciated separately. The estimated useful lives, residual values and depreciation methods are reviewed at the end of each reporting period, with the effects of any changes in the estimates accounted for on a prospective basis.

On derecognition of an item of property, plant and equipment, the difference between the sales proceeds and the carrying amount of the asset is recognized in profit or loss.

h. Investment properties

Investment properties are properties held to earn rentals and/or for capital appreciation. Investment properties also include land held for a currently undetermined future use.

Investment properties are measured initially at cost, including transaction costs, and are subsequently measured using the fair value model. Changes in the fair value of investment properties are included in profit or loss for the period in which they arise.

On derecognition of an investment property, the difference between the net disposal proceeds and the carrying amount of the asset is included in profit or loss.

i. Impairment of property, plant and equipment and right-of-use asset

At the end of each reporting period, the Group reviews the carrying amounts of its property, plant and equipment and right-of-use asset, to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss. When it is not possible to estimate the recoverable amount of an individual asset, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs. Corporate assets are allocated to the smallest group of cash-generating units on a reasonable and consistent basis of allocation.

The recoverable amount is the higher of fair value less costs to sell and value in use. If the recoverable amount of an asset or cash-generating unit is estimated to be less than its carrying amount, the carrying amount of the asset or cash-generating unit is reduced to its recoverable amount, with the resulting impairment loss recognized in profit or loss.

When an impairment loss is subsequently reversed, the carrying amount of the corresponding asset, cash-generating unit or assets related to contract costs is increased to the revised estimate of its recoverable amount, but only to the extent of the carrying amount that would have been determined had no impairment loss been recognized on the asset, cash-generating unit or assets related to contract costs in prior years. A reversal of an impairment loss is recognized in profit or loss.

j. Financial instruments

Financial assets and financial liabilities are recognized when the Group becomes a party to the contractual provisions of the instruments.

15 -

Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss.

1) Financial assets

All regular way purchases or sales of financial assets are recognized and derecognized on a trade date basis.

a) Measurement category

Financial assets are classified into the following categories: Financial assets at amortized cost and financial assets at FVTOCI.

i. Financial assets at amortized cost

Financial assets that meet the following conditions are subsequently measured at amortized cost:

i) The financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows; and
ii) The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

Subsequent to initial recognition, financial assets at amortized cost, including cash and cash equivalents, notes receivable, accounts receivable, other receivables, other current financial assets and refundable deposits, are measured at amortized cost, which equals to gross carrying amount determined using the effective interest method less any impairment loss. Exchange differences are recognized in profit or loss.

Interest income is calculated by applying the effective interest rate to the gross carrying amount of a financial asset, expect for:

i) Purchased or originated credit-impaired financial assets, for which interest income is calculated by applying the credit adjusted effective interest rate to the amortized cost of such financial assets; and
ii) Financial assets that are not credit impaired on purchase or origination but have subsequently become credit impaired, for which interest income is calculated by applying the effective interest rate to the amortized cost of such financial assets in subsequent reporting periods.

Cash equivalents include time deposits with original maturities within 3 months from the date of acquisition, which are highly liquid, readily convertible to a known amount of cash and are subject to an insignificant risk of changes in value. These cash equivalents are held for the purpose of meeting short-term cash commitments.

16 -
ii. Investments in equity instruments at FVTOCI

On initial recognition, the Group may make an irrevocable election to designate investments in equity instruments as at FVTOCI. Designation as at FVTOCI is not permitted if the equity investment is held for trading or if it is contingent consideration recognized by an acquirer in a business combination.

Investments in equity instruments at FVTOCI are subsequently measured at fair value with gains and losses arising from changes in fair value recognized in other comprehensive income and accumulated in other equity. The cumulative gain or loss will not be reclassified to profit or loss on disposal of the equity investments; instead, it will be transferred to retained earnings.

Dividends on these investments in equity instruments are recognized in profit or loss when the Group’s right to receive the dividends is established, unless the dividends clearly represent a recovery of part of the cost of the investment.

b) Impairment of financial assets

The Group recognizes a loss allowance for expected credit losses on financial assets at amortized cost (including trade receivables).

The Group always recognizes lifetime expected credit losses (ECLs) for accounts receivable. For all other financial instruments, the Group recognizes lifetime ECLs when there has been a significant increase in credit risk since initial recognition. If, on the other hand, the credit risk on a financial instrument has not increased significantly since initial recognition, the Group measures the loss allowance for that financial instrument at an amount equal to 12-month ECLs.

Expected credit losses reflect the weighted average of credit losses with the respective risks of default occurring as the weights. Lifetime ECLs represent the expected credit losses that will result from all possible default events over the expected life of a financial instrument. In contrast, 12-month ECLs represent the portion of lifetime ECLs that is expected to result from default events on a financial instrument that are possible within 12 months after the reporting date.

For internal credit risk management purposes, the Group determines that internal or external information show that the debtor is unlikely to pay its creditors indicate that a financial asset is in default.

The impairment loss of all financial assets is recognized in profit or loss by a reduction in their carrying amounts through a loss allowance account.

c) Derecognition of financial assets

The Group derecognizes a financial asset only when the contractual rights to the cash flows from the asset expire or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another party.

On derecognition of a financial asset at amortized cost in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in profit or loss. On derecognition of an investment in an equity instrument at FVTOCI, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in profit or loss, and the cumulative gain or loss which had been recognized in other comprehensive income is transferred directly to retained earnings, without recycling through loss.

17 -

2) Equity instruments

Debt and equity instruments issued by the Group are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.

Equity instruments issued by the Group are recognized at the proceeds received, net of direct issue costs.

The repurchase of the Company’s own equity instruments is recognized in and deducted directly from equity. No gain or loss is recognized in profit or loss on the purchase, sale, issuance or cancellation of the Company’s own equity instruments.

3) Financial liabilities

a) Subsequent measurement

Except the following situations, all financial liabilities are measured at amortized cost using the effective interest method:

Financial liabilities at FVTPL

Financial liabilities are classified as at FVTPL when such financial liabilities are either held for trading or are designated as at FVTPL. Fair value is determined in the manner described in Note 27.

b) Derecognition of financial liabilities

The difference between the carrying amount of a financial liability derecognized and the consideration paid, including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

4) Convertible bonds

The conversion option component of the convertible bonds issued by the Group, which will be settled other than by the exchange of a fixed amount of cash or other financial assets for a fixed number of the Company’s own equity instruments, is classified as a derivative financial liability.

On initial recognition, the derivative financial liability component of the convertible bonds is recognized at fair value, and the initial carrying amount of the non-derivative financial liability component is determined by deducting the amount of the derivative financial liability component from the fair value of the hybrid instrument as a whole. In subsequent periods, the non-derivative financial liability component of the convertible bonds is measured at amortized cost using the effective interest method. The derivative financial liability component is measured at fair value, and the changes in fair value are recognized in profit or loss. Transaction costs that relate to the issuance of the convertible notes are allocated to the derivative financial liability component and the non-derivative financial liability component in proportion to their relative fair values.

k. Revenue recognition

The Group identifies contracts with customers, allocates the transaction price to the performance obligations and recognizes revenue when performance obligations are satisfied.

18 -

Revenue from the sale of goods comes from sales of cellulose acetate tow and cellulose acetate. Sales of cellulose acetate tow and cellulose acetate are recognized as revenue when the goods are shipped because it is the time when the customer has the primary responsibility for sales to future customers and bears the risks of obsolescence. Trade receivables are recognized concurrently.

l. Leasing

At the inception of a contract, the Group assesses whether the contract is, or contains, a lease.

1) The Group as lessor

Leases are classified as finance leases whenever the terms of a lease transfer substantially all the risks and rewards of ownership to the lessee. All other leases are classified as operating leases.

Lease payments (less any lease incentives payable) from operating leases are recognized as income on a straight-line basis over the terms of the relevant leases. Initial direct costs incurred in obtaining operating leases are added to the carrying amounts of the underlying assets and recognized as expenses on a straight-line basis over the lease terms.

2) The Group as lessee

The Group recognizes right-of-use assets and lease liabilities for all leases at the commencement date of a lease, except for short-term leases and low-value asset leases accounted for applying a recognition exemption where lease payments are recognized as expenses on a straight-line basis over the lease terms.

Right-of-use assets are initially measured at cost, which comprises the initial measurement of lease liabilities adjusted for lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs needed to restore the underlying assets, and less any lease incentives received. Right-of-use assets are subsequently measured at cost less accumulated depreciation and impairment losses and adjusted for any remeasurement of the lease liabilities. Right-of-use assets are presented on a separate line in the consolidated balance sheets.

Right-of-use assets are depreciated using the straight-line method from the commencement dates to the earlier of the end of the useful lives of the right-of-use assets or the end of the lease terms.

m. Borrowing costs

Borrowing costs directly attributable to an acquisition, construction or production of qualifying assets are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.

Other than that which is stated above, all other borrowing costs are recognized in profit or loss in the period in which they are incurred.

n. Government grants

Government grants are not recognized until there is reasonable assurance that the Group will comply with the conditions attached to them and that the grants will be received.

Government grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which they become receivable.

19 -

o. Employee benefits

1) Short-term employee benefits

Liabilities recognized in respect of short-term employee benefits are measured at the undiscounted amount of the benefits expected to be paid in exchange for the related services.

2) Retirement benefits

The Group participates in the local government pension plans in accordance with local regulations, contributing pension regularly to the government according to a certain percentage of the employee’s salary. Payments to defined contribution retirement benefit plans are recognized as expenses for the current period when employees have rendered services entitling them to the contributions.

p. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

1) Current tax

According to the People’s Republic of China (PRC) Enterprise Income Tax Law, the tax rate is 25%. Jinan Acetate Chemical Co., Ltd (China) of the Group has acquired the High-tech Enterprise Certificate in 2018; Acetek Material Co., Ltd (China) of the Group has acquired the High-tech Enterprise Certificate in 2019. The applicable tax rate for both companies is 15%. The High-tech Enterprise Certificate of Jinan Acetate Chemical Co., Ltd (China) and Acetek Material Co., Ltd (China) will expire in November 2021 and November 2022. Adjustments of prior years’ tax liabilities are added to or deducted from the current year’s tax provision.

2) Deferred tax

Deferred tax is recognized on temporary differences between the carrying amounts of assets and liabilities and the corresponding tax bases used in the computation of taxable profit.

Deferred tax liabilities are generally recognized for all taxable temporary differences. Deferred tax assets are generally recognized for all deductible temporary differences and unused loss carryforwards to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilized.

The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the assets to be recovered. A previously unrecognized deferred tax asset is also reviewed at the end of each reporting period and recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.

Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in which the liabilities are settled or the assets are realized, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from the manner in which the Group expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. If investment properties measured using the fair value model are non-depreciable assets, the carrying amounts of such assets are presumed to be recovered entirely through sale.

20 -
3) Current and deferred taxes for the year

Current and deferred taxes are recognized in profit or loss, except when they relate to items that are recognized in other comprehensive income or directly in equity; in which case, the current and deferred taxes are also recognized in other comprehensive income or directly in equity, respectively.

5. CRITICAL ACCOUNTING JUDGMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the Group’s accounting policies, management is required to make judgments, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.

The Group considers the economic implications of the COVID-19 when making its critical accounting estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised if the revisions affect only that period or in the period of the revisions and future periods if the revisions affect both current and future periods.

6. CASH AND CASH EQUIVALENTS

December 31 2020 2019 Cash on hand $ 147 $ 162 Demand deposits 831,183 453,953 Cash equivalents (investments with original maturities of less than 3 months) Time deposits - 135,146 $ 831,330 $ 589,261 FINANCIAL INSTRUMENTS AT FAIR VALUE THROUGH PROFIT OR LOSS December 31 2020 2019 Financial liabilities held for trading-current Derivative financial liabilities (not under hedge accounting) Convertible options (Note 18) $ 21,450 $ 46,300 Foreign exchange forward contracts 348 - $ 21,798 $ 46,300 Financial liabilities held for trading-non-current Derivative financial liabilities (not under hedge accounting) Convertible options (Note 18) $ 61,140 $ -		December 31	December 31
			2019 $ 162 453,953 135,146 $ 589,261 31
		2020 $ 21,450 348 $ 21,798 $ 61,140	2019 $ 46,300 - $ 46,300 $ -

7. FINANCIAL INSTRUMENTS AT FAIR VALUE THROUGH PROFIT OR LOSS

21 -

At the end of the year, outstanding foreign exchange forward contracts not under hedge accounting were as follows:

					Notional Amount
			Currency	Maturity Date	(In Thousands)
December	31,	2020
Sell			USD/RMB	2021.1	USD1,500/RMB9,800
Sell			USD/RMB	2021.2	USD1,500/RMB9,820
Sell			USD/RMB	2021.3	USD1,500/RMB9,840
Sell			USD/RMB	2021.4	USD1,500/RMB9,857
Sell			USD/RMB	2021.5	USD1,500/RMB9,874
Sell			USD/RMB	2021.6	USD1,500/RMB9,892

8. FINANCIAL ASSETS AT FAIR VALUE THROUGH OTHER COMPREHENSIVE INCOME

Investments in equity instruments at FVTOCI

Non-current Foreign investments Unlisted shares Ordinary shares - ELEUNG LIMITED		December	31
		2020 $ 25,829	2019 $ 31,716

The Group holds 25% of the ordinary shares of ELEUNG LIMITED. However, according to the shareholders’ agreement, the owner shareholders shall have the control in the composition of company’s board of directors, moreover, the Group has no authority to participate in the investee’s financial and operating policy decisions; therefore, the investment is not accounted for as an associated company.

These investments in equity instruments are held for medium to long-term strategic purposes. Accordingly, the management elected to designate these investments in equity instruments as at FVTOCI as they believe that recognizing short-term fluctuations in these investments’ fair value in profit or loss would not be consistent with the Group’s strategy of holding these investments for long-term purposes.

9. FINANCIAL ASSETS AT AMORTIZED COST

Current Domestic investments Time deposits with original maturities of more than 3 months		December	31
		2020 $ 4,865	2019 $ 98,106

a. The ranges of interest rates for time deposits with original maturities of more than 3 months were approximately 0.40%-1.85% and 1.69%-2.85% per annum as of December 31, 2020 and 2019, respectively.
b. Refer to Note 29 for information relating to investments in financial assets at amortized cost pledged as security.
22 -

10. NOTES RECEIVABLE AND ACCOUNTS RECEIVABLE

Notes and accounts receivable At amortized cost Gross carrying amount Less: Allowance for impairment loss Accounts receivable from related parties At amortized cost Gross carrying amount Less: Allowance for impairment loss		December 31	December 31
		2020 $ 586,078 - $ 586,078 $ 75,387 - $ 75,387	2019 $ 350,644 - $ 350,644 $ 87,249 - $ 87,249

The Group takes advance payments for the sales of goods through letters of credit. The credit period of sales of goods was between 30 and 180 days. No interest was charged on trade and notes receivable. The Group adopted a policy of only dealing with entities that are rated the equivalent of investment grade or higher and obtaining sufficient collateral, where appropriate, as a means of mitigating the risk of financial loss from defaults. The Group uses other publicly available financial information or its own trading records to rate its major customers. The Group’s exposure and the credit ratings of its counterparties are continuously monitored and the aggregate value of transactions concluded is spread amongst approved counterparties.

The Group measures the loss allowance for trade receivables at an amount equal to lifetime ECLs. The expected credit losses on accounts receivable are estimated using a provision matrix by reference to the past default experience of the debtor and an analysis of the debtor’s current financial position, adjusted for general economic conditions of the industry in which the debtors operate and an assessment of both the current as well as the forecasted direction of economic conditions at the reporting date. As the Group’s historical credit loss experience does not show significantly different loss patterns for different customer segments, the provision for loss allowance based on past due status is not further distinguished according to the Group’s different customer base.

The following table details the loss allowance of accounts receivable based on the Group’s provision matrix.

December 31, 2020

1 to 30 Days 31 to 60 Days 61 to 90 Days Expected credit loss rate 0% 0% 0% Gross carrying amount $ 238,911 $ 153,968 $ 107,272 Loss allowance (Lifetime ECL) - - - Amortized cost $ 238,911 $ 153,968 $ 107,272	91 to 120 Days 0% $ 70,827 - $ 70,827	121 to 180 Days 0% $ 90,487 - $ 90,487	181 to 360 Days 0% $ - - $ -	Total $ 661,465 -
				$ 661,465

23 -

December 31, 2019

1 to 30 Days 31 to 60 Days 61 to 90 Days Expected credit loss rate 0% 0% 0% Gross carrying amount $ 191,560 $ 109,729 $ 33,355 Loss allowance (Lifetime ECL) - - - Amortized cost $ 191,560 $ 109,729 $ 33,355	91 to 120 Days 0% $ 43,659 - $ 43,659	121 to 180 Days 0% $ 59,590 - $ 59,590	181 to 360 Days 0% $ - - $ -	Total $ 473,893 -
				$ 473,893

The total balance of accounts receivable increased by $223,572 thousand and $125,830 thousand as of December 31, 2020 and 2019 compared to the beginning balance, respectively. After the assessment, the Group did not recognize allowance for impairment loss on receivables as of December 31, 2020 and 2019.

11. INVENTORIES

Finished goods Work in progress Raw materials Supplies		December 31	December 31
		2020 $ 59,157 20,198 120,712 19,912 $ 219,979	2019 $ 77,927 17,648 125,622 21,772 $ 242,969

The cost of inventories recognized as cost of goods sold for the years ended December 31, 2020 and 2019 was $1,564,853 thousand and $1,501,761 thousand, respectively. The inventory write-downs (reversals of inventory write-downs) was $267 thousand and $657 thousand, respectively.

12. SUBSIDIARIES

a. Entities included in the consolidated financial statements:

Investor
Investee
Nature of Activities
The Company
My Parents Living Technology Limited
(Hong Kong) (“My Parents”)
Investments
My Parents
Jinan Acetate Chemical Co., Ltd.
(China) (“Jinan Acetate Chemical”)
Production and sales of
cellulose acetate tow
Jinan Acetate Chemical
Acetek Material Co., Ltd. (China)
(“Acetek Material”)
Production and sales of
cellulose acetate
My Parents
Acetek Material Co., Ltd. (China)
(“Acetek Material”)
Production and sales of
cellulose acetate
My Parents
Acetek Chemical Co., Ltd. (China)
(“Acetek Chemical”)
Investments
Jinan Acetate Chemical
Acetek Momentun Co., Ltd. (China)
(“Acetek Momentun”)
Manufacturing and sales
of cellulose anhydride
My Parents
Acetek Momentun Co., Ltd. (China)
(“Acetek Momentun”)
Manufacturing and sales
of cellulose anhydride

Proportion of Ownership

December 31

2020
2019
100.00
100.00
100.00
100.00
52.80
52.80
27.20
27.20
80.00
80.00
(Note 1)
43.01
(Note 2)
-
56.99
(Note 2)
-

Note 1: The Group invested in Acetek Chemical in March 2019.

Note 2: The Group invested in Acetek Momentun in July 2020 by Jinan Acetate Chemical and December 2020 by My Parents.

24 -

b. Details of subsidiaries that have material non-controlling interests

Name of Subsidiary Principal Place of Business Acetek Material Mainland China	Proportion of Ownership and Voting Rights Held by Non-controlling Interests
	December 31
	2020 2019 20.00% 20.00%

Summarized financial information in respect of Acetek Material that has material non-controlling interests is set out below. The summarized financial information below represents amounts before intragroup eliminations.

Current assets Non-current assets Current liabilities Equity Equity attributable to: Owners of the Company Non-controlling interests of Acetek Material Revenue Profit for the year Other comprehensive income for the year Total comprehensive income for the year Profit attributable to: Owners of the Company Non-controlling interests of Acetek Material Total comprehensive income attributable to: Owners of the Company Non-controlling interests of Acetek Material			December 31	December 31
	2020 2019 $ 329,960 $ 238,642 788,039 765,513 (562,697) (481,296) $ 555,302 $ 522,859 $ 444,242 $ 418,287 111,060 104,572 $ 555,302 $ 522,859 For the Year Ended December 31
		2020 $ 1,029,941 $ 23,184 (20,385) $ 2,799 $ 18,547 4,637 $ 23,184 $ 2,239 560 $ 2,799		2019 $ 1,042,238 $ 11,126 20,283 $ 31,409 $ 8,901 2,225 $ 11,126 $ 25,127 6,282 $ 31,409 (Continued)

25 -

Net cash inflow from: Operating activities Investing activities Financing activities Effects of exchange rate changes Net cash outflow	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ (91,282) (99,775) 175,080 7,861 $ (8,116)	2019 $ 53,119 (69,555) - 6,950 $ (9,486) (Concluded)

13. PROPERTY, PLANT AND EQUIPMENT

Cost Balance at January 1, 2019 Additions Disposals Reclassification Effect of foreign currency exchange differences Balance at December 31, 2019 Accumulated depreciation Balance at January 1, 2019 Depreciation expenses Disposals Effect of foreign currency exchange differences Balance at December 31, 2019 Carrying amounts at December 31, 2019 Cost Balance at January 1, 2020 Additions Disposals Reclassification Effect of foreign currency exchange differences Balance at December 31, 2020 Accumulated depreciation Balance at January 1, 2020 Depreciation expenses Disposals Effect of foreign currency exchange differences Balance at December 31, 2020 Carrying amounts at December 31, 2020	Buildings $ 200,374 25,596 - 4,924 (8,621) $ 222,273 $ 46,349 12,224 - (2,188) $ 56,385 $ 165,888 $ 222,273 9,165 - 591 3,934 $ 235,963 $ 56,385 11,598 - 1,200 $ 69,183 $ 166,780	Equipment Transportation Equipment $ 983,432 $ 9,072 42,756 279 (1,240 ) - 87,133 2,205 (41,507) (432) $ 1,070,574 $ 11,124 $ 370,783 $ 5,258 80,442 1,733 (1,192 ) - (16,785) (262) $ 433,248 $ 6,729 $ 637,326 $ 4,395 $ 1,070,574 $ 11,124 50,654 - - (478 ) 30,597 287 19,708 182 $ 1,171,533 $ 11,115 $ 433,248 $ 6,729 88,361 1,752 - (454 ) 9,206 141 $ 530,815 $ 8,168 $ 640,718 $ 2,947	Other Equipment Construction in Progress Equipment $ 7,530 $ 87,853 - 15,822 - - - (87,553 ) (281) (593) $ 7,249 $ 15,229 $ 2,041 $ - 1,472 - - - (131) - $ 3,382 $ - $ 3,867 $ 15,229 $ 7,249 $ 15,229 - 81,189 - - - (12,803 ) 120 1,771 $ 7,369 $ 85,386 $ 3,382 $ - 1,409 - - - 88 - $ 4,879 $ - $ 2,490 $ 85,386	Total $ 1,288,261 84,453 (1,240 ) 6,409 (51,434) $ 1,326,449 $ 424,431 95,871 (1,192 ) (19,366) $ 499,744 $ 826,705 $ 1,326,449 141,008 (478 ) 18,672 25,715 $ 1,511,366 $ 499,744 103,120 (454 ) 10,635 $ 613,045 $ 898,321

26 -

The above items of property, plant and equipment are depreciated on a straight-line basis over their estimated useful lives as follows:

Buildings	20 years
Equipment	3-10 years
Transportation equipment	4-5 years
Other equipment	5 years

Property, plant and equipment pledged as collateral for bank borrowings are set out in Note 29.

14. LEASE ARRANGEMENTS

a. Right-of-use assets

Carrying amount Land Depreciation charge for right-of-use assets Land		December	31
	2020 2019 $ 53,811 $ 55,248 For the Year Ended December 31
		2020 $ 2,256	2019 $ 2,356

b. Material leasing activities and terms

As lessees, Jinan Acetek Chemical Co., Ltd. and Acetek Material Co., Ltd. are leasing certain lands for the use of factory with lease terms of 20 to 30 years. These arrangements do not contain purchase options at the end of the lease terms.

c. Other lease information

Expenses relating to short-term leases Expenses relating to low-value asset leases Total cash outflow for leases	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ 433 $ 14 $ (447)	2019 $ 411 $ 12 $ (423)

The Group leases of certain office equipment qualify as short-term leases and leases of certain computer equipment which qualify as low-value asset leases. The Group has elected to apply the recognition exemption and thus, did not recognize right-of-use assets and lease liabilities for these leases.

27 -

15. INVESTMENT PROPERTIES

Measured at fair value		December 31	December 31
		2020 $ 101,897	2019 $ 100,220

As lessor, the Group is leasing the abovementioned investment properties for 9 years. The lessees do not have bargain purchase options to acquire the investment properties at the expiry of the lease periods.

The maturity analysis of lease payments receivable under operating leases of investment properties at December 31, 2020 was as follows:

Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 onwards		December	31
		2020 $ 4,473 4,473 4,696 4,696 4,931 4,931 $ 28,200	2019 $ 4,535 4,671 4,671 4,905 4,905 10,299 $ 33,986

Investment Properties Measured at Fair Value

Balance at January 1, 2020 Effects of foreign currency exchange differences Balance at December 31, 2020 Balance at January 1, 2019 Effects of foreign currency exchange differences Balance at December 31, 2019	Total $ 100,220 1,677 $ 101,897 $ 104,108 (3,888) $ 100,220

The fair values of investment properties were measured on a recurring basis as follows:

Independent valuation		December 31	December 31
		2020 $ 101,897	2019 $ 100,220

The fair values of a single investment property with a carrying amount at least 20% of the paid-in capital at December 31, 2020 and 2019 were based on the valuations carried out on January 28, 2021 and March 9, 2020, respectively, by independent qualified professional valuer, Mr. Ming-Hun Tsai, from Zhan-Mao Real Estate Appraisal Firm and Mr. Yi-chuan Chang, from Da-Hua Real Estate Appraisal Firm, a Certified Real Estate Appraiser in the ROC.

28 -

The movements in the fair value of investment properties within Level 3 of the hierarchy were as follows:

Balance at January 1, 2020 Recognized in other comprehensive income (exchange differences on translating the financial statements of foreign operations) Balance at December 31, 2020 Balance at January 1, 2019 Recognized in other comprehensive income (exchange differences on translating the financial statements of foreign operations) Balance at December 31, 2019	Total $ 100,220 1,677 $ 101,897 $ 104,108 (3,888) $ 100,220

The fair value of investment properties, except for undeveloped land, was measured using the income approach. The significant assumptions used are as follows:

Expected future cash inflows Expected future cash outflows Expected future cash inflows, net Discount rates		December 31	December 31
		2020 $ 217,877 (8,342) $ 209,535 5.38%	2019 $ 262,310 (5,841) $ 256,469 6%

The market rentals in the area where the investment property is located were between RMB7.758 per square meter. The market rentals for comparable properties were between RMB7 and RMB9 per square meter.

The investment property has 1 floor above ground level, and the floor had been leased out under operating leases. The rental income generated for the years ended December 31, 2020 and 2019 was $4,289 thousand and $4,479 thousand, respectively.

The future cash inflows expected to be generated by investment properties include rental income, interest income on rental deposits and disposal value. The rental income was extrapolated using the Group’s current rental rate, taking into account the annual rental growth rate; the income analysis covers a 10-year period, the interest income on rental deposits was extrapolated using the time deposit interest rate for 1-year period; there was no disposal value since after the land lease expires, no land owner will be paid back the above-ground houses. The expected future cash outflows incurred by investment properties included the expenditures such as enterprise-establishing brokerage fee, related taxes and management costs, insurance premiums and maintenance costs. These expenditures were extrapolated on the basis of the current level of expenditures, taking into account the future adjustments.

The discount rate of 5.38% was determined using the interest rate for 1-year time deposits as posted by The People’s Bank of China of 1.75% and long-term interest rate of 4.75% for the year ended December 31, 2020. The discount rate was first calculated by using 50% of funds and borrowing for capitalization rate of 3.215%, then calculated by liquidity, risk, appreciation and the difficulty on management.

29 -

The discount rate of 6% was determined using the interest rate for 3-year time deposits as posted by The People’s Bank of China of 2.75% and any asset-specific risk premiums of 3.25% for the year ended December 31, 2019.

The Group has free hold interests in all of its investment properties. The investment properties pledged as collateral for bank borrowings are set out in Note 29.

16. OTHER ASSETS

17.	Current Prepayments Advanced payments Prepayment Others Other current assets Refundable deposits Non-current Other non-current assets Prepayments for equipment Refundable deposits Prepayments for house BORROWINGS Short-term Borrowings Unsecured borrowings Line of credit borrowings		December	31
			2020 $ 26,384 19,680 17,918 $ 63,982 $ 92,318 $ 81,940 27 10 $ 81,977 December	2019 $ 5,992 39,100 9,227 $ 54,319 $ 67,065 $ 19,679 26 1,378 $ 21,083 31
			2020 $ 56,960	2019 $ 299,800

The range of interest rates on bank loans was 0.85%-1.05% and 2.52%-3.05% per annum at December 31, 2020 and 2019, respectively.

30 -

18. BONDS PAYABLE

First-time unsecured domestic convertible bonds (ROC) Second-time unsecured domestic convertible bonds (ROC)		December 31	December 31
		2020 $ 473,921 513,646 $ 987,567	2019 $ 456,564 - $ 456,564

As of June 9, 2017, the Company issued $500,000 thousand, 0% NTD-denominated unsecured convertible bonds in Taiwan, with a total issue amount of $500,000 thousand.

Each bond entitles the holder to convert it into ordinary shares of the Company at a conversion price of $173. In case of ex-right or ex-dividend, the price should be adjusted according to the conversion price adjustment formula. The conversion price as of December 31, 2020 was $137. Conversion may occur at any time between September 10, 2017 and June 9, 2022. If the bonds have not been converted and the closing price of ordinary shares has exceeded 30% of the current conversion price for 30 consecutive business days, the Company may send a copy of “Debt Rebate Notice” with expiration of one month by registered mail within the next 30 business days. The aforementioned period is calculated from the delivery of mail, and the expiration date of the period is determined as the base date for recovery of bonds. The Company redeems the bonds at their par value within 5 business days following the base date.

The convertible bonds shall be resold in advance by bondholders on the date of the issuance of 3 years (June 9, 2020) and the date of the issuance of 4 years (June 9, 2021). The Company should send a copy of “Notice of Put Provision” to the bondholders by registered mail in 40 days before the base date of resale. The bondholders may require the Company to add interest compensation to the par value of the bonds (101.5075% for 3 years and 102.0151% for 4 years) and to redeem the bonds in cash. Upon receiving the request for resale, the Company shall redeem the bonds in cash within 5 business days after the resale date.

Proceeds from issuance (less transaction costs of $4,499 thousand)

Liability component at the date of issue

Liability component at January 1, 2019 (bonds payable of $439,842 thousand and
financial liabilities at fair value through profit or loss - non-current of $46,400
thousand)

Interest charged at an effective interest rate of 3.7371%
Valuation profit on financial investments

Liability component at December 31, 2019 (bonds payable of $456,564 thousand and
financial liabilities at fair value through profit or loss - current of $46,300 thousand)

Liability component at January 1, 2020 (bonds payable of $456,564 thousand and
financial liabilities at fair value through profit or loss - current of 46,300 thousand)

Interest charged at an effective interest rate of 3.7371%
Valuation profit on financial investments

Liability component at December 31, 2020 (bonds payable of $473,921 thousand and
financial liabilities at fair value through profit or loss - current of $21,450 thousand)

$ 500,501
$ 500,501
$ 486,242
16,722

(100)
$ 502,864
$ 502,864
17,357

(24,850)
$ 495,371

As of September 25, 2020, the Company issued $600,000 thousand, 0% NTD-denominated unsecured convertible bonds in Taiwan, with a total issue amount of $600,000 thousand.

31 -

Each bond entitles the holder to convert it into ordinary shares of the Company at a conversion price of $130.7. In case of ex-right or ex-dividend, the price should be adjusted according to the conversion price adjustment formula. The conversion price as of December 31, 2020 was $130.7. Conversion may occur at any time between December 26, 2020 and September 25, 2025. If the bonds have not been converted and the closing price of ordinary shares has exceeded 30% of the current conversion price for 30 consecutive business days, the Company may send a copy of “Debt Rebate Notice” with expiration of one month by registered mail within the next 30 business days. The aforementioned period is calculated from the delivery of mail, and the expiration date of the period is determined as the base date for recovery of bonds. The Company redeems the bonds at their par value within 5 business days following the base date.

The convertible bonds shall be resold in advance by bondholders on the date of the issuance of 3 years (September 25, 2023) and the date of the issuance of 4 years (September 25, 2024). The Company should send a copy of “Notice of Put Provision” to the bondholders by registered mail in 40 days before the base date of resale. The bondholders may require the Company to add interest compensation to the par value of the bonds (100.75% for 3 years and 101.00% for 4 years) and to redeem the bonds in cash. Upon receiving the request for resale, the Company shall redeem the bonds in cash within 5 business days after the resale date.

Proceeds from issuance (less transaction costs of $4,584 thousand)

Liability component at the date of issue

Liability component at September 25, 2020 (bonds payable of $509,136 thousand and
financial liabilities at fair value through profit or loss - non-current of $92,280
thousand)

Interest charged at an effective interest rate of 3.2888%
Valuation profit on financial investments

Liability component at December 31, 2020 (bonds payable of $513,646 thousand and
financial liabilities at fair value through profit or loss - non-current of $61,140
thousand)

$ 601,416
$ 601,416
$ 601,416
4,510

(31,140)
$ 574,786

19. OTHER PAYABLES

Payables for purchases of equipment Payables for security production fee Payables for steam fee Payables for salaries Payables for freight Accrued remuneration to employees and directors Others		December 31	December 31
		2020 $ 34,969 28,553 23,801 19,165 18,320 5,122 26,966 $ 156,896	2019 $ 48,579 13,389 20,606 21,244 11,897 5,351 36,222 $ 157,288

20. RETIREMENT BENEFIT PLANS

Jinan Acetate Chemical and Acetek Material of the Group adopted a defined contribution plan. Under the plan, an entity makes contributions to employees’ pension account at percentages of the salary of employees. The pension account is managed by the authorized insurance institution located in China. The employees can withdraw the pension contributed by the Company and by themselves as well as the interest upon retirement.

32 -

21. EQUITY

a. Ordinary shares

Number of shares authorized (in thousands) Shares authorized Number of shares issued and fully paid (in thousands) Shares issued		December 31	December 31
		2020 100,000 $ 1,000,000 51,077 $ 510,767	2019 100,000 $ 1,000,000 51,077 $ 510,767

On March 26, 2019, the Company’s board of directors resolved to issue 4,597 thousand ordinary shares from capital surplus with a par value of $10, of which increased the share capital issued and fully paid to $510,767 thousand.

b. Capital surplus

May be used to offset a deficit, distributed as cash dividends, or transferred to share capital (1) Issuance of ordinary shares May be used to offset a deficit only Changes in percentage of ownership interest in subsidiary (2)		December 31	December 31
		2020 $ 416,034 17,541 $ 433,575	2019 $ 416,034 17,541 $ 433,575

1) Such capital surplus may be used to offset a deficit; in addition, when the Company has no deficit, such capital surplus may be distributed as cash dividends or transferred to share capital (limited to a certain percentage of the Company’s capital surplus and once a year).
2) Such capital surplus arises from the effect of changes in ownership interest in a subsidiary that resulted from equity transactions other than actual acquisition.
c. Retained earnings and dividend policy

The Company is in the growing stage. According to the Articles of Incorporation, the board of directors should propose the distribution of shareholders’ dividends and submit it to the shareholders’ meeting for appropriations of earnings, only after taking into consideration the Company’s earnings, overall development, financial planning, capital requirements, industry outlook and future prospects of the Company for each of the fiscal year.

During the period when the shares are listed or traded in Taipei Exchange or Taiwan Stock Exchange, the board of directors when making proposal for distribution of earnings shall first appropriate the earnings in each fiscal year as follows: (i) reserve for tax of the relevant fiscal year; (ii) amount to offset past losses; (iii) from the remaining amount, 10% for legal reserve; and (iv) special reserve required by the securities authorities of the Republic of China in accordance with the rules of a public company. For the policies on the distribution of employees’ compensation and remuneration of directors and supervisors after the amendment, refer to employees’ compensation and remuneration of directors and supervisors in Note 23-8.

33 -

After considering the financial, business and operational factors, according to the Cayman Company Law and the Public Company Rules, all or parts of the unappropriated earnings accumulated in previous years, plus no less than 10% of the after-tax earnings in the current year, can be distributed as shareholders’ dividends according to the shareholding ratio. Shareholders’ dividends are distributed as stock dividends, cash dividends, or both; cash dividends must not be less than 10% of total dividends.

Appropriation of earnings to legal reserve shall be made until the legal reserve equals the Company’s paid-in capital. The legal reserve may be used to offset deficits. If the Company has no deficit and the legal reserve has exceeded 25% of the Company’s paid-in capital, the excess may be transferred to capital or distributed in cash.

Items referred to under Rule No. 1010012865 and Rule No. 1030006415 issued by the FSC should be appropriated to or reversed from a special reserve by the Company.

The appropriations of earnings for 2019 and 2018 approved in the shareholders’ meetings on June 23, 2020 and June 28, 2019, respectively, were as follows:

Legal reserve Special reserve Cash dividends Cash dividends per share (NT$)	Appropriation of Earnings	Appropriation of Earnings	Appropriation of Earnings
	For the Year Ended		December 31
		2019 $ 32,968 $ 57,195 $ 237,649 $ 4.7	2018 $ 22,510 $ 19,062 $ 183,868 $ 4

The Company’s board of directors at the meeting on March 26, 2019, also resolved to transfer capital surplus of $45,967 thousand to capital.

The appropriations of earnings for 2020 had been proposed by the Company’s board of directors on March 5, 2021. The appropriations and dividends per share were as follows:

	For the Year	For the Year
		Ended
	December 31,
		2020
Legal reserve	$	50,458
Reversed special reserve	$	(15,389)
Cash dividends	$	274,960
Share dividends	$	74,989
Cash dividends per share (NT$)	$	5.5
Share dividends per share (NT$)	$	1.5

The appropriation of earnings for 2020 are subject to the resolution in the shareholders’ meeting to be held on April 15, 2021.

34 -

d. Special reserves

Beginning at January 1 Appropriations in respect of Debits to other equity items Balance at December 31	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ 21,406 57,195 $ 78,601	2019 $ 2,344 19,062 $ 21,406

On the initial application of the fair value model to investment properties, the Company appropriated to retained earnings a special reserve in the amount of $2,344 thousand that was the same as the net increase in the fair value. Additional special reserve should be appropriated for the amount equal to the difference between net debit balance reserves and the special reserve appropriated on the first-time adoption of IFRSs. Any special reserve appropriated may be reversed to the extent that the net debit balance reverses and is thereafter distributed.

e. Non-controlling interests

Balance at January 1 Share in profit (loss) for the year Other comprehensive loss during the year Exchange differences on translating the financial statements of foreign entities Unrealized loss on financial assets at FVTOCI Acquisition of non-controlling interests in subsidiaries Balance at December 31	For the Year Ended	For the Year Ended	December 31
		2020 $ 113,380 5,023 1,981 (1,256) - $ 119,128	2019 $ 109,295 1,580 (4,628) (2,649) 9,782 $ 113,380

f. Treasury shares

	Shares
	Transferred to
	Employees
	(In Thousands
Purpose of Buy-back	of Shares)
Number of shares at January 1, 2020	513
Increase during the year	571
Number of shares at December 31, 2020	1,084
Number of shares at January 1, 2019	426
Increase during the year	87
Number of shares at December 31, 2019	513

Under the Securities and Exchange Act, the Company shall neither pledge treasury shares nor exercise shareholders’ rights on these shares, such as the rights to dividends and to vote.

35 -

22. REVENUE

Revenue from contracts with customers Revenue from sale of goods	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ 2,353,380	2019 $ 2,174,990

a. Contract information

The goods are sold at the fair value of the consideration received or receivable. The Company eliminates the estimated customer returns, discounts and other similar discounts from the amount of goods sold to determine the revenue from sale of goods.

b. Contract balances

December 31, 2020 December 31, 2019 Accounts receivables (Note 10) $ 661,465 $ 437,893 Contract liabilities - current $ 47,573 $ 16,450	January 1, 2019 $ 312,063
	$ 7,196

c. Disaggregation of revenue

Refer to Note 34 for information about disaggregation of revenue.

23. NET PROFIT

a. Other income

Government subsidy income Rental income Miscellaneous income	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ 17,378 4,289 27,410 $ 49,077	2019 $ 13,147 4,479 9,233 $ 26,859

b. Other gains and losses

Net foreign exchange loss Loss on disposal of property, plant and equipment Others	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ (2,635) (22) (623) $ (27,010)	2019 $ (16,503) (34) (2,691) $ (19,228)

36 -

c. Finance costs

For the Year Ended	For the Year Ended	December 31
2020 $ 21,867 3,993 $ 25,860 For the Year Ended		2019 $ 16,722 6,625 $ 23,347 December 31
2020 $ 1,778 For the Year Ended		2019 $ 2,833 December 31
2020 $ 103,120 2,256 $ 105,376 $ 97,260 8,116 $ 105,376 For the Year Ended		2019 $ 95,871 2,356 $ 98,227 $ 91,266 6,961 $ 98,227 December 31
2020 $ 539 For the Year Ended		2019 $ 555 December 31
	2020 $ 93,647 826 4,002 $ 98,475	2019 $ 90,035 7,681 4,435 $ 102,151 (Continued)

37 -

An analysis of employee benefits expense by function Operating costs Operating expenses	For the Year Ended	For the Year Ended	December 31
		2020 $ 52,954 45,521 $ 98,475	2019 $ 55,271 46,880 $ 102,151 (Concluded)

h. Employees’ compensation and remuneration of directors and supervisors

According to the Articles of Incorporation of the Company, the Company accrues employees’ compensation at a rate of no less than 1% when the Company earned profits in the year. Employees’ compensation is paid to employees of subordinate companies that meet certain conditions. When the

Company is able to increase the amount of profit, it accrues directors’ remuneration at a rate of no more than 3% of the profit of the year. However, if the Company has accumulated losses, it should first retain the amount to offset the losses before accruing employees’ and directors’ remuneration in accordance with the above-mentioned proportion. The aforementioned profit refers to the Company’s pre-tax net profit. To avoid confusion, the pre-tax net profit refers to the amount before the accrual for employees and directors’ remuneration.

The employees’ compensation and the remuneration of directors for the years ended December 31, 2020 and 2019, which were approved by the Company’s board of directors on March 5, 2021 and March 27, 2020, respectively, were as follows:

Accrual rate

Employees’ compensation Remuneration of directors Amount Employees’ compensation Remuneration of directors	For the Year Ended December 31	For the Year Ended December 31
	2020 2019 1.00% 1.00% 0.20% 0.60% For the Year Ended December 31
	2020 Cash $ 5,122 1,000	2019
		Cash $ 3,351 2,000

If there is a change in the proposed amounts after the annual consolidated financial statements are authorized for issue, the differences are recorded as a change in accounting estimate in the subsequent period.

There is no difference between the actual amounts of employees’ compensation and remuneration of directors paid and the amounts recognized in the consolidated financial statements for the years ended December 31, 2019 and 2018.

Further information on the employees’ compensation and remuneration of directors approved in the meetings of the board of directors is available at the “Market Observation Post System” website of the TSE.

38 -
i. Gains or losses on foreign currency exchange

Foreign exchange gains Foreign exchange losses Net loss	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ 43,242 (69,607) $ (26,365)	2019 $ 11,059 (27,562) $ (16,503)

24. INCOME TAXES

a. Income tax expense recognized in profit or loss

Current tax In respect of the current year Adjustments for prior year Deferred tax In respect of the current year Adjustments for prior year Change in tax rate Income tax expense recognized in profit or loss	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ (44,944) (10,247) 6,568 5,354 - $ (43,269)	2019 $ (33,256) 1,333 (241) (36) (14,904) $ (47,104)

A reconciliation of accounting profit and income tax expense is as follows:

Profit before income tax Income tax expense calculated at the statutory rate Research and development credits Nondeductible expenses in determining taxable income Tax-exempt income Change in tax rate Adjustments for prior years’ tax Others Income tax expense recognized in profit or loss Current tax assets and liabilities Current tax assets Tax refund receivable	For the Year Ended	For the Year Ended	December 31
		2020 $ 552,850 $ (75,302) 35,384 (366) 2,310 - (4,893) (402) $ (43,269) December	2019 $ 378,361 $ (64,166) 27,883 (228) 2,597 (14,904) 1,297 417 $ (47,104) 31
		2020 $ 3,628	2019 $ 14,028

b. Current tax assets and liabilities

39 -

c. Deferred tax assets and liabilities

The movements of deferred tax assets and deferred tax liabilities are as follows:

For the year ended December 31, 2020

Opening
Balance
Recognized in
Profit or Loss
Exchange
Differences
Deferred tax assets
Temporary differences
Allowance for inventory
valuation and
obsolescence loss
$ 35
$ 36
$ 1

Unrealized compensation
534
(306)
2
FVTPL financial assets
-
51
2
Payables for security
production fee
20,964
7,958
528
Tax losses

-

4,183

92

$ 21,533
$ 11,922
$ 625

Deferred tax liabilities
Temporary differences
Unrealized revaluation
increments
$ 9,420
$ -
$ 157

For the year ended December 31, 2019
Opening
Balance
Recognized in
Profit or Loss
Exchange
Differences
Deferred tax assets
Temporary differences
Allowance for inventory
valuation and
obsolescence loss
$ 87
$ (51)
$ (1)

Unrealized compensation
168
386
(20)
Tax losses

37,295
(15,516)

(815)

$ 37,550
$ (15,181)
$ (836)

Deferred tax liabilities
Temporary differences
Unrealized revaluation
increments
$ 9,785
$ -
$ (365)

Closing
Balance
$ 72
230
53
29,450

4,275
$ 34,080
$ 9,577
Closing
Balance
$ 35
534

20,964
$ 21,533
$ 9,420

Deferred tax assets
Temporary differences
Allowance for inventory
valuation and
obsolescence loss

Unrealized compensation
Tax losses

Deferred tax liabilities
Temporary differences
Unrealized revaluation
increments

40 -

d. Income tax declarations

The income tax declarations of Jinan Acetate Chemical and Acetek Material of the Group have been completed within the deadlines set by the local tax collection office.

25. EARNINGS PER SHARE

Basic earnings per share Diluted earnings per share	Unit: NT$ Per Share For the Year Ended December 31	Unit: NT$ Per Share For the Year Ended December 31	Unit: NT$ Per Share For the Year Ended December 31
		2020 $ 10.07 $ 9.87	2019 $ 6.52 $ 6.40

The earnings and weighted average number of ordinary shares outstanding used in the computation of earnings per share are as follows:

Net Profit for the Year

Profit for the year attributable to owners of the Company Effect of potentially dilutive ordinary shares Interest and evaluation of convertible bonds Earning used in the computation of diluted earnings per share	For the Year Ended	For the Year Ended	December 31
		2020 $ 504,558 35,650 $ 540,208	2019 $ 329,677 16,622 $ 346,299

Number of Shares

Unit: Thousand Shares

Weighted average number of ordinary shares used in the computation of basic earnings per share Effect of potentially dilutive ordinary shares Convertible bonds Employees’ compensation or bonuses issued to employees Weighted average number of ordinary shares used in the computation of diluted earnings per share	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 50,122 4,591 42 54,755	2019 50,567 3,514 32 54,113

If the Group offered to settle the compensation or bonuses paid to employees in cash or shares, then the Group should assume that the entire amount of the compensation or bonuses will be settled in shares, and the resulting potential shares are included in the weighted average number of shares outstanding used in the computation of diluted earnings per share, if the effect is dilutive. Such dilutive effect of the potential shares is included in the computation of diluted earnings per share until the number of shares to be distributed to employees is resolved in the following year.

41 -

26. CAPITAL MANAGEMENT

The Group manages its capital to ensure that it has the necessary financial resources and operating plans to meet the working capital, capital expenditure and debt repayment requirements for the next 12 months, and that entities in the Group will be able to continue as going concerns while maximizing the return to stakeholders through the optimization of the debt and equity balance.

Key management personnel of the Group review the capital structure on a regular basis. As part of this review, the key management personnel consider the cost of capital and the risks associated with each class of capital. Based on recommendations of the key management personnel, in order to balance the overall capital structure, the Group may adjust the amount of dividends paid to shareholders, the number of new shares issued or repurchased, and/or the amount of new debt issued or existing debt redeemed.

27. FINANCIAL INSTRUMENTS

a. Fair value of financial instruments that are not measured at fair value

In the management’s opinion, the carrying value of financial instruments that are not measured at fair value approximates the fair value of the financial instruments.

b. Fair value of financial instruments that are measured at fair value on a recurring basis
1) Fair value hierarchy

December 31, 2020 Financial assets at FVTOCI Investments in equity instruments Financial liabilities at FVTPL Held for trading December 31, 2019 Financial assets at FVTOCI Investments in equity instruments Financial liabilities at FVTPL Held for trading	Level 1 $ - $ - Level 1 $ - $ -	Level 2 $ - $ 82,938 Level 2 $ - $ 46,300	Level 3 $ 25,829 $ - Level 3 $ 31,716 $ -	Total $ 25,829 $ 82,938 Total $ 31,716 $ 46,300

There were no transfers between Levels 1 and 2 for the years ended December 31, 2020 and 2019.

42 -
2) Reconciliation of Level 3 fair value measurements of financial instruments

For the year ended December 31, 2020

Financial Assets
Balance at January 1, 2020
Recognized in profit or loss (included in other gains and losses)
Recognized in other comprehensive income (included in unrealized loss on
investments in equity instruments at FVTOCI)
Balance at December 31, 2020
For the year ended December 31, 2019
Financial Assets
Balance at January 1, 2019
Purchases
Recognized in profit or loss (included in other gains and losses)
Recognized in other comprehensive income (included in unrealized loss on
investments in equity instruments at FVTOCI)
Balance at December 31, 2019

Financial Assets
at FVTOCI

Equity
Instruments
$ 31,716
391

(6,278)
$ 25,829
Financial Assets
at FVTOCI

Equity
Instruments
$ -
47,308
(2,346)
(13,246)
$ 31,716

3) Valuation techniques and inputs applied for Level 2 fair value measurement

==> picture [446 x 13] intentionally omitted <==

----- Start of picture text -----

Financial Instruments Valuation Techniques and Inputs
----- End of picture text -----

Financial Instruments	Valuation Techniques and Inputs
Convertible bonds	The convertible bonds are assumed to be redeemed on June 9,
	2022 and September 25, 2025, and the discount rate is
	calculated by the 5-year public bond yield by the differential
	method.
Derivatives - foreign exchange	Discounted cash flow.
forward contracts
	Future cash flows are estimated based on observable forward
	exchange rates at the end of the year and contract forward
	rates, discounted at a rate that reflects the credit risk of
	various counterparties.

4) Valuation techniques and inputs applied for Level 3 fair value measurement

The fair values of unlisted equity securities - ROC were determined using the income approach. In this approach, the discounted cash flow method was used to capture the present value of the expected future economic benefits to be derived from the ownership of these investees.

43 -

c. Categories of financial instruments

Financial assets Financial assets at amortized cost (Note 1) Financial assets at FVTOCI Equity instruments Financial liabilities Financial liabilities at amortized cost (Note 2) Financial liabilities at FVTPL	December 31
	2020 2019 $ 1,625,587 $ 1,218,478 25,829 31,716 1,359,777 1,137,946 82,938 46,300

1) The balances include financial assets at amortized cost, which comprise cash and cash equivalents, notes receivable and accounts receivable, other receivables, other current assets (pledged deposits) and refundable deposits.
2) The balances include financial liabilities at amortized cost, which comprise short-term borrowings, notes payable, accounts and other payables, bonds issued and guarantee deposit received.
d. Financial risk management objectives and policies

The Group’s major financial instruments include cash and cash equivalents, debt investments, accounts receivable, borrowings, accounts payable and bonds payable. The Group’s Corporate Treasury function provides services to the business, coordinates access to domestic and international financial markets, monitors and manages the financial risks relating to the operations of the Group through internal risk reports which analyze exposures by degree and magnitude of risks. These risks include market risk (including foreign currency risk, interest rate risk and other price risk), credit risk and liquidity risk.

The Group seeks to minimize the effects of these risks by using derivative financial instruments to hedge risk exposures. The use of financial derivatives is governed by the Group’s policies approved by the board of directors, which provided written principles on foreign currency risk, interest rate risk, credit risk, the use of financial derivatives and non-derivative financial instruments, and the investment of excess liquidity. Compliance with policies and exposure limits is reviewed by the internal auditors on a continuous basis. The Group did not enter into or trade financial instruments, including derivative financial instruments, for speculative purposes.

1) Market risk

The Group’s activities exposed it primarily to the financial risks of changes in foreign currency exchange rates (see (a) below) and interest rates (see (b) below).

There has been no change to the Group’s exposure to market risks or the manner in which these risks are managed and measured.

a) Foreign currency risk

Several subsidiaries have foreign currency sales and purchases, which exposes the Group to foreign currency risk. Exchange rate exposures are managed within approved policy parameters utilizing foreign exchange forward contracts.

44 -

The carrying amounts of the Group’s foreign currency denominated monetary assets and monetary liabilities (including those eliminated on consolidation) and of the derivatives exposed to foreign currency risk at the end of the reporting period are set out in Note 32.

Sensitivity analysis

The Group is mainly exposed to the USD.

The following table details the Group’s sensitivity to a 1% increase and decrease in the RMB (i.e. the functional currency) against the relevant foreign currencies. The sensitivity rate used when reporting foreign currency risk internally to key management personnel and representing management’s assessment of the reasonably possible change in foreign exchange rates is 1%. The sensitivity analysis included only outstanding foreign currency denominated monetary items and adjusts their translation at the end of the reporting period for a 1% change in foreign currency rates. A positive number below indicates a decrease in pre-tax profit and other equity associated with the RMB strengthening 1% against the relevant currency. For a 1% weakening of the RMB against the relevant currency, there would be an equal and opposite impact on pre-tax profit and the balances below would be negative.

Profit or loss	USD Impact
	For the Year Ended December 31
	2020 2019 $ 8,609 $ 3,786

The above impact was mainly attributable to the exposure on outstanding receivables and payables in USD which were not hedged at the end of the reporting period.

In the management’s opinion, the sensitivity analysis is not representative of the inherent foreign currency risk because the exposure at the end of the reporting period does not reflect the exposure during the period.

b) Interest rate risk

The Group is exposed to interest rate risk because entities in the Group borrow funds at both fixed and floating interest rates.

The carrying amounts of the Group’s financial assets and financial liabilities with exposure to interest rates at the end of the reporting period were as follows:

Fair value interest rate risk Financial assets Financial liabilities Cash flow interest rate risk Financial assets Financial liabilities	December 31
	2020 2019 $ 4,865 $ 233,253 1,044,527 741,374 922,624 520,584 - 14,990

45 -

Sensitivity analysis

The sensitivity analysis below was based on the Group’s exposure to interest rates for both derivative and non-derivative instruments at the end of the reporting period. For floating rate liabilities, the analysis was prepared assuming the amount of each liability outstanding at the end of the reporting period was outstanding for the whole year. A 100 basis point increase or decrease is used when reporting interest rate risk internally to key management personnel and represents management’s assessment of the reasonably possible change in interest rates.

If interest rates had been 100 basis points higher/lower and all other variables were held constant, the Group’s pre-tax profit for the years ended December 31, 2020 and 2019 would have increased/decreased by $9,226 thousand and $5,056 thousand, which was mainly attributable to the Group’s exposure to interest rates of its variable-rate bank deposits and borrowings.

c) Price risk

The Group was exposed to equity price risk through its investments in equity securities. Equity investments are held for strategic rather than for trading purposes, the Group does not actively trade these investments.

Sensitivity analysis

The sensitivity analysis below was determined based on the exposure to equity price risks at the end of the year. If equity prices had been 1% higher/lower, the pre-tax other comprehensive income for the year ended December 31, 2020 and for the year ended December 31, 2019 would have increased/decreased by $258 thousand and $317 thousand, as a result of the changes in fair value of financial assets at FVTOCI.

2) Credit risk

Credit risk refers to the risk that the counterparty will default on its contractual obligations resulting in financial loss to the Group. As at the end of the reporting period, the Group’s maximum exposure to credit risk, which would cause a financial loss to the Group due to the failure of the counterparty to discharge its obligation, could be equal to the carrying amount of the respective recognized financial assets as stated in the balance sheets.

In order to mitigate credit risk, the management of the Group assigns a team responsible for credit facilities, credit approvals and other monitoring procedures to ensure that appropriate actions are taken for the recovery of overdue receivables. In addition, the Group reviews the recoverable amount of the receivables on the date of the financial statements to ensure that receivables that cannot be recovered have been provided with allowance for impairment loss. Accordingly, the management reckons that the credit risk of the Group has been significantly reduced.

Accounts receivable cover a wide range of customers and are spread across different industries and geographic regions. The Company continuously evaluates the financial position of customers.

In addition, since the counterparty of current funds are financial institutions and companies with good credit ratings, the credit risk is limited.

The Group transacts with a large number of unrelated customers and, thus, no concentration of credit risk was observed.

46 -

3) Liquidity risk

The Group manages liquidity risk by monitoring and maintaining a level of cash and cash equivalents deemed adequate to finance the Group’s operations and mitigate the effects of fluctuations in cash flows. In addition, management monitors the utilization of bank borrowings and ensures compliance with loan covenants.

The Group relies on bank borrowings as a significant source of liquidity. As of December 31, 2020 and 2019, the Group had available unutilized short-term bank loan facilities as set out in (c) below.

a) Liquidity and interest rate risk tables for non-derivative financial liabilities

The following table details the Group’s remaining contractual maturity for its non-derivative financial liabilities with agreed repayment periods. The table has been drawn up based on the undiscounted cash flows of financial liabilities from the earliest date on which the Group can be required to pay. The table included both interest and principal cash flows. Specifically, bank loans with a repayment on demand clause were included in the earliest time band regardless of the probability of the banks choosing to exercise their rights. The maturity dates for other non-derivative financial liabilities were based on the agreed repayment dates.

To the extent that interest flows are at floating rates, the undiscounted amount was derived from the interest rate curve at the end of the reporting period.

December 31, 2020

Non-derivative financial liabilities Non-interest bearing Fixed interest rate liabilities December 31, 2019 Non-derivative financial liabilities Non-interest bearing Variable interest rate liabilities Fixed interest rate liabilities	On Demand or Less than 1 Month $ 84,862 557,004 $ 641,866 On Demand or Less than 1 Month $ 102,248 14,990 165,384 $ 282,622	1-3 Months $ 53,781 - $ 53,781 1-3 Months $ 127,139 - 89,940 $ 217,079	3 Months to 1 Year $ 141,465 - $ 141,465 3 Months to 1 Year $ 155,175 - 529,980 $ 685,155	1-5 Years $ 35,889 600,000 $ 635,889 1-5 Years $ - - - $ -	Total $ 315,997 1,157,004
					$ 1,473,001
					Total $ 384,562 14,990 785,304
					$ 1,184,856

The amount of the variable interest rate liabilities will vary depending on the floating interest rate and the interest rate estimated on the reporting date.

47 -
b) Liquidity risk table for derivative financial liabilities

The following table details the Group’s liquidity analysis of its derivative financial instruments. The table is based on the undiscounted contractual net cash inflows and outflows on derivative instruments that settle on a net basis, and the undiscounted gross inflows and outflows on those derivatives that require gross settlement. When the amount payable or receivable is not fixed, the amount disclosed is determined by reference to the projected interest rates as illustrated by the yield curves at the end of the year.

December 31, 2020

On Demand or Less than 1 Month 1-3 Months Net settled Foreign exchange forward contracts $ 53 $ 121	3 Months to 1 Year $ 174	1-5 Years $ -	5+ Years $ 348

c) Financing facilities

Unsecured bank loan facilities which may be extended by mutual agreement: Amount used Amount unused Secured bank loan facilities which may be extended by mutual agreement: Amount used Amount unused		December 31	December 31
		2020 $ 210,779 718,903 $ 929,682 $ 40,668 81,888 $ 122,556	2019 $ 366,501 380,399 $ 746,900 $ 51,826 107,889 $ 159,715

28. TRANSACTIONS WITH RELATED PARTIES

The Company’s ultimate parent is Jinan Acetate Chemical Co., Ltd.

Balances and transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not disclosed in this note. In addition to those disclosed in other notes, transactions between the Group and its related parties are disclosed below:

a. Related party and relationship with the Group

Relationship with the Group Related Party Name and Other Related Parties Global Filter S.A (GF) Substantive related party Tabacalera Hernandarias S.A. (TH) Substantive related party (Continued)

48 -

Related Party Name

Relationship with the Group and Other Related Parties

SAF - INDUSTRIA E COMERCIO DE FILTEROS LTDA (SAF)

Yan Kuangmeihua Supply And Marketing Limited Company (Yankuang Kuangmeihua)

Yankuang Lunan Chemical Co., Ltd. (Yankuang Lunan Chemical)

JINAN HEZHEN INDUSTRY AND TRADE CO., LTD. (HEZHEN) Wang, Ke-Chang

Substantive related party

Substantive related party (shareholder of a subsidiary) Substantive related party (with the same chairman) Key management

(Concluded)

b. Operating revenue

Line Item Related Party Category/Name Sales Substantive related party GF Others	For the Year Ended	For the Year Ended	December 31
		2020 $ 272,358 100,099 $ 372,457	2019 $ 258,583 43,084 $ 301,667

The selling prices and payment period in related-party transactions were not significantly different from those for transactions with third parties.

c. Purchases of goods

Related Party Category Substantive related party/Yankuang Kuangmeihua Substantive related party/Yankuang Lunan Chemical	For the Year Ended	For the Year Ended	December 31
		2020 $ 194,255 36,892 $ 231,147	2019 $ - 151,741 $ 151,741

The purchase prices in related-party transactions were not significantly different from those for transactions with third parties.

d. Receivables from related parties

Line Item Related Party Category/Name Accounts receivable Substantive related party GF TH SAF		December 31	December 31
		2020 $ 27,728 3,054 44,605 $ 75,387	2019 $ 67,972 16,136 3,141 $ 87,249

The outstanding receivables from related parties were unsecured. For the years ended December 31, 2020 and 2019, no impairment loss was recognized on accounts receivable from related parties.

49 -
e. Payables to related parties

Line Item Related Party Category/Name Notes payable Substantive related party/ Yankuang Lunan Chemical Other payables Substantive related party/ Yankuang Lunan Chemical		December 31	December 31
		2020 $ - 23,801 $ 23,801	2019 $ 13,561 20,606 $ 34,167

The outstanding payables to related parties were unsecured.

f. Prepayments

	December 31	December 31
	2020 2019 $ 25,592 $ - December 31
2020 $ 438 For the Year Ended		2019 $ 431 December 31
	2020 $ 203,639 8,729 360 77 $ 212,805	2019 $ 188,906 8,323 360 89 $ 197,678

g. Refundable deposits (other current assets)
h. Other transactions with related parties

The substantive related party provides steam to the Company for use in production and provides rental service.

The key management provides rental service to the Company.

50 -
i. Endorsements and guarantees

Endorsements and guarantees given by related parties

Substantive related party/HEZHEN Amount endorsed j. Compensation of key management personnel Short-term employee benefits Post-employment benefits		December 31	December 31
	2020 $ - For the Year Ended		2019 $ 25,830 December 31
		2020 $ 8,173 14 $ 8,187	2019 $ 15,652 88 $ 15,740

The remunerations of directors and key executives were determined by the remuneration committee on the basis of individual performance and market trends.

29. ASSETS PLEDGED AS COLLATERAL OR FOR SECURITY

The following assets were provided as collateral for bank borrowings, letters of credit and bank’s acceptance bills:

Financial assets at amortized cost Pledge deposits (classified as other current assets) Property, plant and equipment, net Right-of-use assets Investment properties, net		December 31	December 31
		2020 $ 4,865 91,441 52,492 53,811 74,887 $ 277,496	2019 $ 1,050 66,632 57,001 55,248 73,655 $ 253,586

30. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNIZED COMMITMENTS

In addition to those disclosed in other notes, significant commitments and contingencies of the Group were as follows:

As of December 31, 2020 and 2019, unused letters of credit for purchases of raw materials and machinery and equipment amounted to approximately $196,466 thousand and $0 thousand, respectively.

Unrecognized commitments were as follows:

Payments for property, plant and equipment		December	31
		2020 $ 38,055	2019 $ 25,659

51 -

31. SIGNIFICANT EVENTS AFTER THE REPORTING PERIOD

The Group evaluated the economic impact caused by the COVID-19 epidemic. The Group had no significant influence by the epidemic at the date of consolidated financial report announced. The Group will continue to observe and to evaluate the impact on this relevant epidemic.

32. SIGNIFICANT ASSETS AND LIABILITIES DENOMINATED IN FOREIGN CURRENCIES

The Group entities’ significant financial assets and liabilities denominated in foreign currencies aggregated by the foreign currencies other than functional currencies and the related exchange rates between foreign currencies and respective functional currencies were as follows:

		Foreign		Carrying
	Currencies		Exchange Rate	Amount
December 31, 2020
Financial assets
Monetary items
USD	$	35,360	6.525 (USD:RMB)	$ 1,009,789
Financial liabilities
Monetary items
USD		5,218	6.525 (USD:RMB)	148,856
December 31, 2019
Financial assets
Monetary items
USD		25,091	6.976 (USD:RMB)	753,472
Financial liabilities
Monetary items
USD		12,498	6.976 (USD:RMB)	374,828

The significant (realized and unrealized) foreign exchange gain (losses) were as follows:

Functional Currency USD	For the Year Ended December 31	For the Year Ended December 31
	2020 Exchange Rate Net Foreign Exchange Losses 6.8996 (USD:RMB) $ (26,220)	2019
		Exchange Rate Net Foreign Exchange Losses 6.897 (USD:RMB) $ (16,503)

52 -

33. SEPARATELY DISCLOSED ITEMS

a. Information on significant transactions and investees:
1) Financing provided to others. (Table 1)
2) Endorsements/guarantees provided. (Table 2)
3) Marketable securities held (excluding investment in subsidiaries, associates and joint ventures). (Table 3)
4) Marketable securities acquired and disposed of at costs or prices of at least NT$300 million or 20% of the paid-in capital. (None)
5) Acquisition of individual real estate at costs of at least NT$300 million or 20% of the paid-in capital. (None)
6) Disposal of individual real estate at prices of at least NT$300 million or 20% of the paid-in capital. (None)
7) Total purchases from or sales to related parties amounting to at least NT$100 million or 20% of the paid-in capital. (Table 4)
8) Receivables from related parties amounting to at least NT$100 million or 20% of the paid-in capital. (None)
9) Trading in derivative instruments. (Table 7)
10) Intercompany relationships and significant intercompany transactions. (Table 5)
b. Information on investees. (Table 6)
c. Information on investments in mainland China
1) Information on any investee company in mainland China, showing the name, principal business activities, paid-in capital, method of investment, inward and outward remittance of funds, ownership percentage, net income of investees, investment income or loss, carrying amount of the investment at the end of the period, repatriations of investment income, and limit on the amount of investment in the mainland China area. (Table 7)
2) Any of the following significant transactions with investee companies in mainland China, either directly or indirectly through a third party, and their prices, payment terms, and unrealized gains or losses: (None)
- a) The amount and percentage of purchases and the balance and percentage of the related payables at the end of the period.
- b) The amount and percentage of sales and the balance and percentage of the related receivables at the end of the period.
- c) The amount of property transactions and the amount of the resultant gains or losses.
- d) The balance of negotiable instrument endorsements or guarantees or pledges of collateral at the end of the period and the purposes.
53 -
e) The highest balance, the end of period balance, the interest rate range, and total current period interest with respect to financing of funds.
f) Other transactions that have a material effect on the profit or loss for the period or on the financial position, such as the rendering or receiving of services.
d. Information of major shareholders: List all shareholders with ownership of 5% or greater showing the name of the shareholder, the number of shares owned, and percentage of ownership of each shareholder (Table 8)

34. SEGMENT INFORMATION

a. Financial information of the operating segment

Information reported to the chief operating decision maker for resource allocation and assessment of segment performance focuses on the types of goods and services to be delivered. The Group focuses its business mainly on the manufacturing and sales of cellulose acetate products. According to IFRS 8, the Group has organized management and resource allocation in a single department. The operating activities are related to R&D and manufacturing of acetate products, and the operating income of the operating activities accounts for more than 90% of the total revenue.

b. Revenue from major products and services

The following is an analysis of the Group’s revenue from continuing operations from its major products and services.

Cellulose acetate tow Cellulose acetate	For the Year Ended December 31	For the Year Ended December 31	For the Year Ended December 31
		2020 $ 1,689,914 663,466 $ 2,353,380	2019 $ 1,548,017 626,973 $ 2,174,990

c. Geographical information

The Group operates in four principal geographical areas - Asia, Africa, America and Europe.

The Group’s revenue from continuing operations from external customers by location of operations and information about its non-current assets by location of assets are detailed below.

Asia America Europe Africa	Revenue from External Customers	Revenue from External Customers	Revenue from External Customers
	For the Year Ended December 31
		2020 $ 1,508,612 609,740 176,988 58,040 $ 2,353,380	2019 $ 1,487,505 461,674 172,105 53,706 $ 2,174,990

54 -
d. Information about major customers

Single customers contributing 10% or more to the Group’s revenue were as follows:

Customer A	For the Year Ended	For the Year Ended	December 31
		2020 $ 272,358	2019 $ 258,583

55 -

TABLE 1

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

FINANCING PROVIDED TO OTHERS FOR THE YEAR ENDED DECEMBER 31, 2020 (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

==> picture [1096 x 96] intentionally omitted <==

----- Start of picture text -----

Highest Collateral Financing
Financial Ending Actual Business Reasons for Allowance for Aggregate
Related Balance for Interest Rate Nature of Limit for
No. Lender Borrower Statement Balance Borrowing Transaction Short-term Impairment Financing Note
Party the Period (%) Financing Item Value Each
Account (Note 1) Amount Amount Financing Loss Limit
(Note 1) Borrower
1 Jinan Acetate Chemical Acetek Material Co., - Y $ 175,080 $ 175,080 $ 175,080 5 Short-term $ - Operation $ - - $ - $ 747,905 $ 997,207 Note 3
Co., Ltd. Ltd. (China) (RMB 40,000 (RMB 40,000 (RMB 40,000 financing turnover
thousand) thousand) thousand)
----- End of picture text -----

Note 1: The maximum balance for the period and ending balance represent the amounts approved by the board of directors.

Note 2: For foreign subsidiaries whose voting shares are 100% owned, directly or indirectly, by the Company, when the funds are used for financing, the total amount shall not exceed 100% of the net worth of the lender. The total amount for lending to a company for funding shall not exceed 30% of the net worth of the Company.

Note 3: For companies with short-term funding needs, the amount for lending to a company shall not exceed 30% of the net worth of the lender. The total amount for lending shall not exceed 40% of the net worth of the Company.

Note 4: The limit on the amount for lending is calculated according to the recent financial statements audited by the Company’s independent accountants.

Note 5: Spot buy/sell average exchange rates of Bank of Taiwan on December 31, 2020 are used to estimate the amount in New Taiwan dollar.

Note 6: All transactions listed in the table have been eliminated in the preparation of the consolidated statements.

56 -

TABLE 2

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

ENDORSEMENTS/GUARANTEES PROVIDED FOR THE YEAR ENDED DECEMBER 31, 2020 (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

==> picture [1096 x 210] intentionally omitted <==

----- Start of picture text -----

Endorsee/Guarantee Receiver Ratio of
Limit on Endorsement/
Maximum Accumulated Endorsement/ Endorsement/
Endorsement/ Outstanding Aggregate Guarantee
Amount Amount Endorsement/ Guarantee Guarantee
Guarantee Endorsement/ Actual Endorsement/ Given on
No. Endorser/ Endorsed/ Endorsed/ Guarantee to Given by Given by
Relationship Given on Guarantee at Borrowing Guarantee Behalf of Note
(Note 1) Guarantor Name Guaranteed Guaranteed by Net Equity in Parent on Subsidiaries on
(Note 2) Behalf of Each the End of the Amount Limit Companies in
During the Collaterals Latest Behalf of Behalf of
Party Period (Note 3) Mainland
Period Financial Subsidiaries Parent
(Note 3) China
Statements (%)
0 Jinan Acetate Jinan Acetate Chemical Co., Ltd. b $ 3,723,208 $ 87,540 $ 87,540 $ 45,114 $ - 5.88 $ 3,723,208 Y N Y -
Chemical Co., Ltd. (China)
Acetek Material Co., Ltd. (China) b 446,785 43,770 - - - 2.94 1,489,283 Y N Y -
Acetek Material Co., Ltd. (China) b 446,785 43,770 43,770 - - 2.94 1,489,283 Y N Y Note 4
1 Jinan Acetate Acetek Material Co., Ltd. (China) b 498,603 43,770 43,770 - - 1.76 1,246,509 Y N Y Note 4
Chemical Co., Ltd.
(China)
----- End of picture text -----

Note 1: Significant transactions between the Company and its subsidiaries or among subsidiaries are numbered as follows:

a. “0” for the Company.
b. Subsidiaries are numbered from “1”

Note 2: Relationships between the endorser/guarantor and the endorsee/guarantee receiver:

a. The Company in relation to business.
b. The Company which holds, directly or indirectly, over 50% of the voting shares.
c. The Company which holds, directly or indirectly, over 50% of the shares.
d. The Company which holds, directly or indirectly, over 90% of the voting shares.
e. Based on contract projects among their peers in accordance with contract provisions which need mutual insurance company.
f. Owing to the joint venture funded by the shareholders on its endorsement of its holding company.
g. Compliance guarantees for the performance of the sales contracts of pre-sold homes within the same industry in accordance with the Consumer Protection Law.

Note 3: The calculation for the amount of endorsement is as follows:

a. The total amount of guarantee provided by the Company to any entity whose voting shares are 100% owned, directly and indirectly, shall not exceed two-hundred-and-fifty percent (250%) of the Company’s net worth.
b. The total amount of guarantee provided by the Company to any individual entity shall not exceed ten percent (30%) of the Company’s net worth. Except for the guarantee provided to any entity whose voting shares are 100% owned, the total balance of guarantee shall not exceed the Company’s total net worth.
c. The total amount of guarantee provided by Jinan Acetate Chemical Co., Ltd. (China) shall not exceed fifty percent (50%) of its net worth. The total amount of guarantee provided to any individual entity shall not exceed twenty percent (20%) of its net worth.

Note 4: The Company and Jinan Acetate Chemical Co., Ltd. (China) provide guarantees for Acetek Material Co., Ltd. (China). The balance is RMB10,000,000.

Note 5: The limit on the amount for lending is calculated according to the recent financial statements audited by the Company’s independent accountants.

Note 6: Spot buy/sell average exchange rates of Bank of Taiwan on December 31, 2020 are used to estimate the amount in New Taiwan dollar.

57 -

TABLE 3

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

MARKETABLE SECURITIES HELD DECEMBER 31, 2020

(In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

==> picture [1096 x 129] intentionally omitted <==

----- Start of picture text -----

December 31, 2020
Relationship with the
Type and Name of Marketable Securities Carrying
Holding Company Name Holding Company Financial Statement Account Number of Percentage of Note (Note 4)
(Note 1) Amount Fair Value
(Note 2) Shares Ownership (%)
(Note 3)
Acetek Chemical Co., Ltd. (China) Stock
ELEUNG LIMITED - Financial assets at fair value through 333 $ 25,829 25 $ 25,829 -
other comprehensive income -
non-current
----- End of picture text -----

Note 1: The marketable securities in this table are stocks, bonds and short-term investments accounted for under of “IFRS 9 Financial Instruments”.

Note 2: The parties in the transactions are not significant related parties so the space is empty.

Note 3: Carrying amounts is fair value adjusted for deduction of accumulated impairment loss; otherwise, original carrying amounts at amortized cost after deduction of accumulated impairment loss.

Note 4: Amounts pledged should be noted on the table.

Note 5: The information about subsidiaries, associates and joint ventures is provided in Tables 6 and 7.

58 -

TABLE 4

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

TOTAL PURCHASES FROM OR SALES TO RELATED PARTIES AMOUNTING TO AT LEAST NT$100 MILLION OR 20% OF THE PAID-IN CAPITAL FOR THE YEAR ENDED DECEMBER 31, 2020

(In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

==> picture [1096 x 243] intentionally omitted <==

----- Start of picture text -----

Notes/Accounts Receivable
Transaction Details Abnormal Transaction (Note 1)
(Payable)
Buyer Related Party Relationship Notes
Purchase/
Amount % to Total Payment Terms Unit Price Payment Terms Ending Balance % to Total
Sales
Jinan Acetate Chemical Acetek Material Co., Subsidiary Purchase $ 670,744 38 Same as those for No significant difference No significant difference $ - - Note 2
Co., Ltd. (China) Ltd. (China) unrelated parties
Acetek Material Co., Jinan Acetate Chemical Parent company Sales (670,744) (21) Same as those for No significant difference No significant difference - - Note 3
Ltd. (China) Co., Ltd. (China) unrelated parties
Jinan Acetate Chemical Global Filters S.A. Substantive related party Sales (272,358) (9) Same as those for No significant difference No significant difference 27,728 4.19 -
Co., Ltd. (China) unrelated parties
Acetek Material Co., Yan Kuangmeihua Substantive related party Purchase 194,255 11 Same as those for No significant difference No significant difference - - Note 4
Ltd. (China) Supply And unrelated parties
Marketing Limited
Company
----- End of picture text -----

Note 1: Differences in the condition of transactions between related parties and general customers should be noted on the table.

Note 2: The prepayment of $204,935 thousand; purchase prices have no significant difference from general customers.

Note 3: The advance receipt of $204,935 thousand; sales prices are equivalent to the sales prices for general customers.

Note 4: The prepayment of $25,592 thousand; purchase prices have no significant difference from general customers.

Note 5: Actual capital amount is the actual amount from the parent company, issuer of no par stock or par value stock less than $10 New Taiwan dollar shall follow the actual capital amount as 20% of transaction amount rule; equity is calculated at 10% of the equity in the parent company’s balance sheet.

Note 6: The transactions between the Company and investee companies have been already been eliminated in the preparation of the consolidated financial statements.

59 -

TABLE 5

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

INTERCOMPANY RELATIONSHIPS AND SIGNIFICANT TRANSACTIONS FOR THE YEAR ENDED DECEMBER 31, 2020 (In Thousands of New Taiwan Dollars)

==> picture [1096 x 219] intentionally omitted <==

----- Start of picture text -----

Transaction Details
No. Relationship % to Total Sales
Investee Company Counterparty Financial Statement
(Note 1) (Note 2) Amount Payment Terms or Assets
Account
(Note 3)
0 Jinan Acetate Chemical Co., Ltd. Jinan Acetate Chemical Co., Ltd. (China) 1 Other non-current $ 23,448 In accordance with mutual contracts 0.75
liabilities
1 My Parents Living Technology Limited (Hong Kong) Jinan Acetate Chemical Co., Ltd. (China) 3 Other non-current 192,517 In accordance with mutual contracts 6.19
liabilities
2 Jinan Acetate Chemical Co., Ltd. (China) Acetek Material Co., Ltd. (China) 3 Account receivables 62,395 In accordance with mutual contracts 2.01
Acetek Material Co., Ltd. (China) 3 Other receivables 175,080 In accordance with mutual contracts 5.63
Acetek Material Co., Ltd. (China) 3 Prepayments 204,935 In accordance with mutual contracts 6.59
Acetek Material Co., Ltd. (China) 3 Sales 61,040 In accordance with mutual contracts 2.59
Acetek Material Co., Ltd. (China) 3 Purchases 670,744 In accordance with mutual contracts 28.50
----- End of picture text -----

Note 1: Companies are identified by number, as follows:

a. “0” represents the parent company.
b. “1” represents the subsidiary.

Note 2: The flow of transactions is as follows:

a. 1 - from the parent company to the subsidiary.
b. 2 - from the subsidiary to the parent company.
c. 3 - between subsidiaries.
Note 3: Percentage of consolidated operating revenues or consolidated total assets: If the account is in the balance sheet, it was calculated by dividing the ending balance by the consolidated total assets; if the account is in the income statement, it was calculated by dividing the interim cumulative balance by the consolidated operating revenue.
Note 4: The important transactions listed accord with the materiality principle of the Company.
Note 5: All transactions listed in the table have been eliminated in the preparation of the consolidated statements.
60 -

TABLE 6

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

INFORMATION ON INVESTEES FOR THE YEAR ENDED DECEMBER 31, 2020 (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

==> picture [1096 x 129] intentionally omitted <==

----- Start of picture text -----

Original Investment Amount As of December 31, 2020 Net Income Share of
Main Business
Investor Company Investee Company Location December 31, December 31, Carrying (Loss) of the Profit (Loss) Note
and Product Shares %
2020 2019 Amount Investee (Note 1)
Jinan Acetate Chemical Co., Ltd. My Parents Living Technology Limited Hong Kong Investments $ 861,789 $ 861,789 Note 3 100 $ 2,627,973 $ 436,929 $ 436,929 -
(Hong Kong)
My Parents Living Technology Acetek Chemical Co., Ltd. (China) Hong Kong Investments 39,196 39,196 Note 3 80 21,835 (94) (75) -
Limited (Hong Kong)
----- End of picture text -----

Note 1: The amount was calculated according to the investee company’s financial statement reviewed by accountants and the Company’s shareholding ratio.

Note 2: The share of profit or loss among investee companies and the net worth between investor and investee companies under the equity method are all eliminated at the time the consolidated financial statements are prepared.

Note 3: The investee company is limited and has no shares.

Note 4: Information on investments in Mainland China, please refer to Table 7.

61 -

TABLE 7

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

INFORMATION ON INVESTMENTS IN MAINLAND CHINA FOR THE YEAR ENDED DECEMBER 31, 2020

(In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

==> picture [1096 x 315] intentionally omitted <==

----- Start of picture text -----

Accumulated Remittance of Funds Accumulated
Outward Outward Accumulated
Remittance for Remittance for Ownership of Carrying Repatriation of
Net Income Investment
Main Businesses and Method of Investment Investment Investment Direct or Amount as of Investment
Investee Company Paid-in Capital (Loss) of the Gain (Loss) Note
Products (Note 1) from Taiwan Outward Inward from Taiwan Indirect December 31, Income as of
Investee (Note 2)
as of as of Investment 2020 December 31,
January 1, December 31, 2020
2020 2020
Jinan Acetate Chemical Co., Manufacturing and sales $ 264,171 c $ - $ - $ - $ - $ 435,560 100 $ 435,560 $ 2,361,707 $ - -
Ltd. (China) of cellulose acetate (RMB 62,593 (Note 2 b (2))
tow thousand)
Acetek Material Co., Ltd. Manufacturing and sales 581,452 c - - - - 23,184 80 20,169 454,676 - Note 3
(China) of cellulose acetate (RMB 125,000 (Note 2 b (2))
thousand)
Acetek Momentun Co., Ltd. Manufacturing and sales 148,956 c - - - - (201) 100 (201) 150,401 - -
(China) of cellulose anhydride (RMB 34,409 (Note 2 b (2))
thousand)
Accumulated Outward Remittance Upper Limit on the Amount of
Investment Amounts Authorized by
for Investment in Mainland China Investment Stipulated by
Investment Commission, MOEA
as of December 31, 2020 Investment Commission, MOEA
$ - $ - $ -
----- End of picture text -----

Note 1: Investment is divided into the following three categories which can be marked:

a. Direct investment in mainland China.

b. Reinvestment in mainland China companies through the third region (please indicated the third area of investment company).

c. Others.

Note 2: The investment income (loss) recognized in current period:

a. No investment income (loss) has been recognized due to the investment is still in development stage.

b. The investment income (loss) was determined on the following basis:

1) The financial report was audited and certified by an international accounting firm in cooperation with accounting firm in the ROC.

2) The financial statements were audited by the CPA of the parent company in Taiwan.

3) Others.

Note 3: The realized and unrealized profits and losses among the companies were considered.

62 -

TABLE 8

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES INFORMATION OF MAJOR SHAREHOLDERS DECEMBER 31, 2020

==> picture [501 x 104] intentionally omitted <==

----- Start of picture text -----

Shares
Name of Major Shareholder Number of Percentage of
Shares Ownership (%)
BRIGHT PEARL ENTERPRISES LTD. 18,010,300 35.26
MACRIFER TRADING SOCIEDAD ANONIMA 8,648,200 16.93
AMACRON TRADING LIMITED 3,756,100 7.35
----- End of picture text -----

Note 1: The information of major shareholders presented in this table is provided by the Taiwan Depository & Clearing Corporation based on the number of ordinary shares and preferred shares held by shareholders with ownership of 5% or greater, that have been issued without physical registration (including treasury shares) by the Company as of the last business day for the current quarter. The share capital in the consolidated financial statements may differ from the actual number of shares that have been issued without physical registration because of different preparation basis.
Note 2: If a shareholder delivers the shareholdings to the trust, the above information will be disclosed by the individual truster who opened the trust account. For shareholders who declare insider shareholdings with ownership greater than 10% in accordance with the Security and Exchange Act, the shareholdings include shares held by shareholders and those delivered to the trust over which shareholders have rights to determine the use of trust property. For information relating to insider shareholding declaration, please refer to Market Observation Post System.
63 -

AI assistant

ACE — Audit Report / Information 2020

52427_rns_2020-11-13_03e4e636-d3a9-4a57-bd1e-ee1299e28589.pdf

INDEPENDENT AUDITORS’ REPORT

Opinion

Basis for Opinion

Key Audit Matters

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Notice to Readers

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS DECEMBER 31, 2020 AND 2019

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019 (In Thousands of New Taiwan Dollars)

JINAN ACETATE CHEMICAL CO., LTD. AND SUBSIDIARIES

1. GENERAL INFORMATION

2. APPROVAL OF FINANCIAL STATEMENTS

3. APPLICATION OF NEW, AMENDED AND REVISED STANDARDS AND INTERPRETATIONS

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

e. Foreign currencies

f. Inventories

g. Property, plant and equipment

1) Financial assets

a) Measurement category

2) Equity instruments

3) Financial liabilities

Financial liabilities at FVTPL

l. Leasing

1) The Group as lessor

m. Borrowing costs

n. Government grants

o. Employee benefits

1) Short-term employee benefits

2) Retirement benefits

1) Current tax

5. CRITICAL ACCOUNTING JUDGMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

6. CASH AND CASH EQUIVALENTS

7. FINANCIAL INSTRUMENTS AT FAIR VALUE THROUGH PROFIT OR LOSS

8. FINANCIAL ASSETS AT FAIR VALUE THROUGH OTHER COMPREHENSIVE INCOME

9. FINANCIAL ASSETS AT AMORTIZED COST

10. NOTES RECEIVABLE AND ACCOUNTS RECEIVABLE

December 31, 2019

11. INVENTORIES

12. SUBSIDIARIES

13. PROPERTY, PLANT AND EQUIPMENT

14. LEASE ARRANGEMENTS

15. INVESTMENT PROPERTIES

Investment Properties Measured at Fair Value

16. OTHER ASSETS

18. BONDS PAYABLE

19. OTHER PAYABLES

20. RETIREMENT BENEFIT PLANS

21. EQUITY

a. Ordinary shares

d. Special reserves

e. Non-controlling interests

f. Treasury shares

22. REVENUE

a. Contract information

b. Contract balances

c. Disaggregation of revenue

23. NET PROFIT

b. Other gains and losses

c. Finance costs

Accrual rate

24. INCOME TAXES

b. Current tax assets and liabilities

c. Deferred tax assets and liabilities

d. Income tax declarations

25. EARNINGS PER SHARE

Net Profit for the Year

Number of Shares

Unit: Thousand Shares

ACE Audit Report / Information 2020